1
CURRICULUM VITAE
Marvin I. Schwarz, M.D.
The James C. Campbell Professor of Pulmonary Medicine
Division of Pulmonary Sciences & Critical Care Medicine
Department of Medicine
University of Colorado, Denver School of Medicine
PERSONAL:
Birthdate:
Birthplace:
Wife:
Children:
June 19, 1938
Monticello, New York
Kathleen Post
Timothy, Jonathan, Susan, Whitney
CONTACT INFORMATION:
University of Colorado Denver
Anschutz Medical Campus
RC 2, Mail Stop C-272
12700 East Nineteenth Ave
Aurora, Colorado 80045
(H) (303) 696-7138
(W) (303) 724-6108
(F) (303) 724-6042
E-mail: Marvin.Schwarz@UCDenver.edu
EDUCATION:
1960 B.A. - Bard College, Annondale-on-Hudson, New York
1964
M.D. - Tulane University School of Medicine, New Orleans, Louisiana
INTERNSHIP:
1964 - 1965
Internal Medicine, Tulane Service, Charity Hospital of Louisiana, New Orleans, Louisiana
RESIDENCY:
1965 - 1967
Internal Medicine, Tulane Service, Charity Hospital of Louisiana (George Burch, M.D.), New
Orleans, Louisiana
FELLOWSHIP:
1967 - 1969
Pulmonary Disease and Critical Care Medicine, Tulane University School of Medicine (Morton
M. Ziskind, M.D.), New Orleans, Louisiana
2009 – 2011
Genetics in Pulmonary Fibrosis, Genetic and Environmental Health Center (D Schwartz) National
Jewish Health, Denver CO
2
MILITARY SERVICE:
1969 - 1972
Assistant Chief, Pulmonary Disease Service and Chief, Pulmonary Function Laboratory, Walter
Reed General Hospital, Washington, D.C., U.S. Army Medical Corp., Rank - Major, Honorable
Discharge
CERTIFICATION:
1970 1971 1987 - 1997
Diplomate, American Board of Internal Medicine
Diplomate, Pulmonary Disease Subspecialty Board
Added Certificate in Critical Care Medicine (28605)
LICENSURE:
Colorado (17784)
ACADEMIC POSITIONS AND HOSPITAL APPOINTMENTS:
1966 - 1969
Instructor in Internal Medicine, Tulane University School of Medicine, New Orleans, LA
1972 - 1977
Assistant Professor of Medicine, University of Colorado School of Medicine, Denver, CO
1972 - 1974
Chief, Pulmonary Section, Rose Medical Center, Denver, CO
1973 - 1974
Staff Physician, Pulmonary Division, Veterans Administration Medical Center, Denver, CO
1973 - 1994
Consultant to the Army in Pulmonary Disease, Fitzsimons Army Medical Center, Denver, CO
1974 - 1988
Chief, Pulmonary Section, Veterans Administration Hospital, Denver, CO
1977 - 1986
Associate Professor of Medicine, University of Colorado School of Medicine, Denver, CO
1982 - 1999
Consulting Staff, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO
1985 - 1987
Co-Head, Division of Pulmonary Sciences & Critical Care Medicine, University of Colorado
Health Sciences, Denver CO
3
1985 Consulting Staff, Denver Health Medical Center, Denver, CO
1985 - 1993
Director, Medical Intensive Care Unit, University Hospital, Denver, CO
1985 - 2007
Director, Respiratory Care Services and Pulmonary Function Laboratory, University Hospital,
Denver, CO
1986 Professor of Medicine, University of Colorado Health Sciences Center, Denver, CO
1985- 2004
Head, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health
Sciences Center, Denver, CO
1987 - 2010
Director, Fellowship Training Program, Division of Pulmonary Sciences and Critical Care
Medicine, University of Colorado Health Sciences Center, Denver, CO
1996 The James C. Campbell Professor of Pulmonary Medicine [Endowed Chair], University of
Colorado Health Sciences Center, Denver, CO
1999 - 2010
Medical Staff, National Jewish Medical and Research Center
2004 Director of Development, Division of Pulmonary Sciences and Critical Care Medicine, University
of Colorado at Denver and Health Sciences Center, Denver, CO
PROFESSIONAL SOCIETIES:
American Thoracic Society
Colorado Trudeau Society
Society of Colorado Pulmonary Physicians
American Federation of Clinical Research
New York Academy of Sciences
Association of Pulmonary and Critical Care Program Directors
American Heart Association
Society of Critical Care Medicine
European Respiratory Society
Society for the Advancement of Science
American Association of Subspecialty Professors
American Association of Respiratory Care
American Association For The Advancement of Science
4
HONORS:
Alpha Omega Alpha Medical Honor Society, Tulane University School of Medicine
Musser Burch Society
Fellow of the American College of Physicians
Fellow of the American College of Chest Physicians
Western Society of Clinical Research
Western Association of Physicians
Endowed Chair, the James C. Campbell Professor of Pulmonary Medicine - 1996
Colorado Pulmonary Hall of Fame (Elected Member) - 2000
Presidential Citation and Honorary Lectureship, American College of Chest Physicians - 2003
Leonard Hudson Lifetime Achievement Award, John Butler Lung Conference - 2005
8th Annual Robert Schrier Award for Excellence, Department of Medicine, University of
Colorado at Denver and Health Sciences Center – 2004
Establishment of the Marvin I. Schwarz Endowed Chair for Pulmonary Medicine, University of
Colorado at Denver and Health Sciences Center - 2005
Establishment of the Marvin I. Schwarz Research Award, Coalition for Pulmonary Fibrosis – 2005
John Butler Lung Conference, Master of Case Discussions Award - 2007
The 2008 Edward Livingston Trudeau Medalist, American Thoracic Society
Honorary Lifetime Membership, American Thoracic Society - 2008
OTHER:
Selected by Peers for Listing In:
Town and Country magazine as one of the Outstanding Medical Specialists in the United States,
November, 1989
The Best Doctors In America, Woodward/White, Inc., Aikin, SC, 1992 - 1993
The Best Doctors In America, Woodward/White, Inc., Aikin, SC, 1994 - 1995
Town and Country magazine as one of the Outstanding Medical Specialists in the United States,
February 1995
Who's Who in America, 1995
The Best Doctors In America, Central Region, Woodward and White, Aikin, SC, 1996 - 1997
2000 Best Doctors in the USA. M M Braun Publications, New York City, NY, 1997
The Best Doctors in America, Woodward and White, Aikin, SC 1996 - 1997
The Best Doctors in America, Woodward and White, Aikin, SC 1998-1999
America’s Top Doctors, Castle Connolly Medical, Ltd., 2000-2001.
The Best Doctors in America, Woodward and White, Aikin, SC, 2001-2002.
America’s Top Doctors, 2nd Edition, Castle Connolly Medical, Ltd., 2002-2003.
Best Doctors in America, Woodward and White, Aiken, SC 2002-2003.
America’s Top Doctors, 3rd Edition, Castle Connolly Medical, Ltd., 2003-2004.
Guide to America’s Top Physicians, Consumer Research Council of America, 2003-2004
America’s Top Doctors, 4th Edition, Castle Connolly Medical, Ltd. 2004-2005
Best Doctors in America, Woodward and White, Aiken, SC, 2003-2004
America’s Top Doctors, 5th Edition, Castle Connolly Medical, Ltd 2005-2006
Best Doctors in America, Woodward and White, Aiken, SC, 2004-2005
Best Doctors in America, Woodward and White, Aiken, SC, 2005-2006
America’s Top Doctor’s, 6th Edition, Castle Connolly, Ltd 2006-2007
Guide to Americas Top Physicians, Consumer Research Council of America 2006-2007
5
Best Doctors in America, Woodward and White, Aiken, SC 2006-2007
Colorado’s Top Doctors 2007, Core Magazine 2007
Best Doctors in America, Woodward and White, Aiken, SC 2007-2008
Guide to Americas Top Physicians, Consumer Research Council of America, 2007-2008
America’s Top Doctor’s, 7th Edition, Castle Connolly, Ltd 2007-2008
America’s Top Doctor’s, 8th Edition, Castle Connolly, Ltd 2008-2009
Best Doctors in America, Woodward-White, 2009-2010
Americas Top Doctors, 9th Edition, Castle Connolly Ltd 2009-2010
Top 75 Reviewers for CHEST 2009
Top Reviewers for CHEST, 2010
Best Doctors in America, 2011 – 2012
US News Top Doctors Woodward White, 2011Americas Top Doctors Castle Connolly Medical LTD, 2010 – 2011
Americas Top Doctors Castle Connolly Medical LTD, 2011 – 2012
MEDICAL SCHOOL AND HOSPITAL COMMITTEES:
Student Admissions Committee 1982 - 1992
Adult Quality Assurance Committee 1985 - 1993
Faculty Senate 1985 - 1987, 1989 - 2001
Faculty Council 1985 – 1986
Course Director Medicine 8011, Pulmonary Medicines 1985 Chairman, Medical Records Committee, University Hospital 1988 -1999
Operations Council 1989 - 1993
Faculty Enrichment Council 1989 - 1990
Tenure Positions Committee 1991 - 1992
Long Range Planning Committee - Centers of Excellence 1991 - 1992
Chairman, Senate Ad Hoc Committee, Divisional Status Emergency Medicine, 1992
Design Review Group 1992
Deans Blue Ribbon Tenure Review Committee 1993 - 1994
Inpatient Task Force for University Hospital - National Jewish Center Merger 1994 - 1995
Outpatient Task Force for University Hospital - National Jewish Center Merger 1994 - 1995
General Patient Related Issues Task Force - National Jewish Merger 1994 - 1995
Adult Program Task Force - National Jewish Merger 1994 - 1995
Dean's Intradepartmental Program Review Committee 1995
Task Force - Graduate Medical Education Reform 1995
WGMIW Task Force (merger) 1995
Search Committee for Executive Vice President, Medical and Clinical Services, NJCIRM 1996
Search Committee, Chairman of Medicine, NJCIRM 1996
Space Committee, School of Medicine, 1996 Dean's Philanthropic Committee, 1997 - 2000
Dean's Committee on VA Tenure, 1997 - 1998
Dean’s Research Space Planning Committee (9th Avenue Backfill Advisory Committee), 1999ENT Department Head Search Committee - 1999
Subcommittee on Space Principles - 2000
Dean’s CU Ball Tables Committee, 1999 - 2000
6
School of Medicine Research Retreat Committee for Research Support from Philanthropic
Sources, 2001
Colorado Multiple Institutional Review Board Committee, 2002 - 2004
Deans Search Committee, Chair-Department of Medicine, 2002 – 2004
Vice Chancellors Advisory Committee for Reappointment, Tenure and Promotion 2008 – 2009
Deans Bridge Funding, Grant Review Committee 2008 DEPARTMENTAL AND DIVISIONAL COMMITTEES:
Intern Selection Committee 1976 - 1995, 1997 - 1999, 2002 - 2008
Executive Faculty Committee 1976 - 1985
Director of 4th Year Student Clerkships 1976 - 1985
Pulmonary Division Fellowship Selection Committee 1972 Division Head Committee, Department of Medicine, 1985 - 2004
Head, Pulmonary Sciences Division Executive Faculty Committee 1985 - 1995
Cardiology Division Head Search Committee 1989 - 1991
Post-tenure Review Committee 1989 - 1991
Lung Endowment Board 1992 Strategic Planning Committee 1995 Research Review Committee, Division of Pulmonary Sciences and Critical Care Medicine 1996 Head, Clinical and Fellowship Committee, Division of Pulmonary Sciences and Critical Care
Medicine 1996 Medical Genetics Head, Search Committee, Department of Medicine, 1998 - 2000
Finance Committee, Department of Medicine, 2002
Professors Promotions Committee, Department of Medicine, 2006 Search Committee, Chairman of Medicine, National Jewish Medical and Research Center, 2006 2008
Post-tenure Review Committee, Department of Medicine, 2007Head, T32 Research Oversight Committee, Pulmonary Diseases 2008 –
Schrier Research Day Committee
NATIONAL POSITIONS AND CONSULTANCIES
Aspen Lung Conference, Steering Committee 1975 American College of Physicians, MKSAP VII, Pulmonary and Critical Care Medicine
Subcommittee 1983 - 84
Residency Review Committee for Internal Medicine, Accreditation Council for Graduate Medical
Education 1983 - 1996
Aspen Lung Conference, Co-Chairman Annual Meeting 1984
Aspen Lung Conference (ILD), Chairman Annual Meeting 1985
American Thoracic Society, Research Fund Dinner Committee 1985 - 1997
Western Society Clinical Investigation, President, Respiration Club 1985 - 1988
Colorado Chapter American College of Physicians, Scientific Program Chairman, January,
Critical Care National Board Review Course, Co-Chairman, Denver, CO, 1987
Thomas L. Petty Aspen Lung Conference Director 1989 - 2011
American College of Physicians, American Thoracic Society, MKSAP in the Subspecialty of
Pulmonary Medicine and Critical Care 1991 - 1994
American Thoracic Society, Ad Hoc Committee Proposed Requirements for Training in
Pulmonary and Critical Care 1992 - 1993
7
American Thoracic Society, Council of Representatives 1993 - 1994
HLS, Clinical Systems - National Advisor 1993 Genentech Inc. - Consultant 1993
Western Society of Clinical Research, Membership Selection Committee - 1995
American Thoracic Society, Committee on Postgraduate Education 1994 - 1997
American Thoracic Society, Committee on Clinical Guidelines for Idiopathic Pulmonary Fibrosis
1994 - 1995
American Thoracic Society, Asthma Research Campaign, Member, National Committee
1994 - 1996
American Thoracic Society, Nominating Committee, Section on Clinical Problems 1995
The Lymphangioleiomyomatosis Foundation, Scientific Advisory Board 1995 Association of Subspecialty Professors, Accreditation Committee 1994 - 1995
American College of Physicians and American Thoracic Society, MKSAP (1) in the Subspecialty
of Pulmonary and Critical Care Medicine 1995 - 1997
American Thoracic Society, Pulmonary and Critical Care Training Committee 1997 -1999
National Institutes of Health, Advisory Council, Development of New Antituberculosis
Regiments 1997 - 1999
National Heart, Blood and Lung Institute, ad hoc Committee, Treatment of Interstitial Lung
Disease 1998
Accreditation Council of Graduate Medical Education, Pulmonary-Critical Care Medicine Appeals
Committee 1998 American College of Physicians and American Thoracic Society MKSAP (2) in the Subspecialty
of Pulmonary and Critical Care Medicine (Chairman) 1996 - 1998
American College of Chest Physicians - Leadership Development Committee, 1999
American Thoracic Society, Awards Committee, 2000
Pulmonary Fibrosis Foundation, Founder and Director of Medical Scientific Advisory Board,
2000 - 2003, Member of Medical Advisory Board 2004 National Institutes of Health Working Group, Future Research Directions in Idiopathic Pulmonary
Fibrosis - 2001
Actelion, Ltd. - Consultant, 2000
Coalition for Pulmonary Fibrosis Organizing Committee, 2001
Coalition for Pulmonary Fibrosis, Chairman, Board of Directors, 2001Consultant to the American College of Chest Physicians Interstitial and Diffuse Lung Disease
Network, 2001
Actelion Pharmaceuticals, Chairman, Fibrosis Steering Committee, 2001 - 2003
Actelion Pharmaceuticals, Member BREATHE Scientific Advisory Board, 2001 - 2004
Glaxo-Wellcome Pharmaceuticals, Consultant, 2001
Immunex Pharmaceuticals, Consultant, 2001
Centocor, Inc., Consultant, 2001
InterMune Advisory Board, 2002 - 2004
American Thoracic Society, Revenue Development Committee, 2002 - 2005
Genzyme Corporation, Pulmonary Fibrosis Working Group, 2002
Pulmonary Fibrosis Foundation, Member Scientific Advisory Board, 2002 Coalition for Pulmonary Fibrosis, Board of Directors, 2003 Abbott Laboratories, Consultant, 2003
Chair, Search Committee for Editor of “Chest,” American College of Chest Physicians,
2003-2005
8
Member, Nominating Committee for Honorary Lectureships, American College of Chest
Physicians 2004 –
Chairman, Board of Directors, Aspen Lung Conference, 2001 – 2010
National Heart Blood and Lung Institute, Member Steering Committee and Representative to the
Protocol Review Committee, The Lung Tissue Research Consortium, 2003 – 2010
National Heart Blood and Lung Institute, Member Idiopathic Pulmonary Fibrosis Network
Steering Committee - Chair, Advanced Disease Protocol; Member, Ethics Committee;
Member, Protocol Review Committee; Member, Marketing Committee; Member, Acute
Exacerbation Adjudication Committee; Member Education Committee 2005 –
Chair, Publication Committee 2011, Chair IPF-Network Steering Committee 2011, Member
Executive Committee 2011
The France Foundation, Faculty of the Pilot Workgroup on Idiopathic Pulmonary Fibrosis, 2005 –
2007
Actelion Pharmaceuticals, Build 3 Study, Chair Data Safety Monitoring Board; 2007 – 2010
National Institute of Health, Health of the Population, Fellowship Review Special Emphasis Panel,
Member 2006 – 2008
Respiratory Clinical Endpoint Committee, Merck Pharmaceuticals, 2007American Thoracic Society, International Long Range Planning Task Force, 2007 – 2008
National Heart Blood and Lung Institute, Steering Committee, T32 Program Directors, Lung
Division, 2007 – 2008
Centocor, Phase II, IPF Protocol (CNTO 888), Data Safety Monitoring Board, Member and Chair,
` 2008 –
Novartis, Albumen – Interferon Trial in Chronic Hepatitis C, Member, Risk Management
Advisory Group 2008 National Heart Lung and Blood Institute, Special Emphasis Panel, R03, Small Grants for Lung
Tissue Research 2008 – 2009
Novartis, Anti-IL-13 Trial for IPF, Consultant, 2009
Pfizer, Pulmonary Fibrosis, Consultant, Presentation (Recent Developments in IPF) 2010
American Thoracic Society, Co-Chairman, Third Annual ATS Foundation Research Dinner 2010
Novartis, Chairman, Data Safety Monitoring Board, Phase 2a trial of oax576 in IPF - 2010 –
Boehringer Ingelheim, Medical Advisory Board 2012
VISITING PROFESSOR AND INVITED SPEAKER: 1984 – Present
1984
Invited Speaker, St. Joseph Hospital, Phoenix, Arizona - Grand Rounds, "Eosinophilic
Pneumonias"
Invited Speaker, Tri-state Pulmonary Conference, Biloxi, MI - "Bronchoalveolar Lavage: Clinical
Use"
Visiting Professor, Tulane University, New Orleans, LA - Grand Rounds, "Idiopathic Pulmonary
Fibrosis"
Visiting Professor, University of Washington, Seattle, WA - "Idiopathic Pulmonary Fibrosis"
Invited Speaker, American Thoracic Society - Meet The Professor, "Idiopathic Pulmonary
Fibrosis"
Invited Speaker, National Pulmonary Board Review Course, San Francisco, CA - "Radiology for
the Pulmonary Physician"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
9
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1985
Invited Speaker, American College of Physicians, Board Review Course, Phoenix, AZ "Interstitial Lung Disease"
Visiting Professor, Hahnemann University School of Medicine, Philadelphia, PA - "Idiopathic
Pulmonary Fibrosis"
Visiting Professor, Walter Reed Army Medical Center, Washington, D.C. - Grand Rounds,
"Idiopathic Pulmonary Fibrosis"
Visiting Professor, University of Arkansas Health Science Center, Little Rock, AR - Grand
Rounds, "Idiopathic Pulmonary Fibrosis"
Invited Speaker, American Thoracic Society - Meet The Professor, "Sarcoidosis"
Invited Speaker, MKSP Review Course American College of Physicians, Denver, CO "Interstitial Lung Disease"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish
Center for Immunology and Respiratory Medicine, Denver, CO "Chest X-ray
Interpretation"
1986
Invited Speaker, National Pulmonary Board Review Course, San Francisco, CA - "Radiology for
the Pulmonary Physician"
Visiting Professor, Northeastern Ohio Universities College of Medicine, Canton, OH - Grand
Rounds, "Interstitial Lung Disease"
Invited Speaker, American Thoracic Society - Plenary Session, "Idiopathic Pulmonary Fibrosis"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1987
Invited Speaker, Critical Care Board Review Course, Denver, CO - "Neuromuscular Emergencies"
Visiting Professor, Brown University, School of Medicine, Providence, RI – Grand Rounds,
"Idiopathic Pulmonary Fibrosis"
Visiting Professor, University of California, School of Medicine, San Francisco, CA - Grand
Rounds, "Idiopathic Pulmonary Fibrosis"
Invited Speaker, American Thoracic Society, Las Vegas, NV - "Update on Interstitial Lung
Disease"
Invited Speaker, American College of Physicians, National Meeting, New York, NY - "Update on
Interstitial Lung Disease"
Invited Speaker, National Pulmonary Board Review Course, Denver, CO - "Radiology for the
Pulmonary Physician"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1988
Visiting Professor, Maine Medical Center, Portland, ME - Grand Rounds, “Idiopathic Pulmonary
Fibrosis"
Invited Speaker, American College of Chest Physicians - Meet the Professor, "Idiopathic
Pulmonary Fibrosis"
Invited Speaker, International Interstitial Lung Disease Symposium, Tokyo, Japan - Speaker, "The
Diagnosis and Assessment of the Course of Idiopathic Pulmonary Fibrosis" and "The
Relationship of BAL to Histopathology and Therapeutic Responsiveness in Idiopathic
Pulmonary Fibrosis"
10
Invited Speaker, American Thoracic Society - Meet the Professor, "Update in Interstitial Lung
Disease"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1989
Invited Speaker, Oregon Thoracic Society, Portland, OR - Speaker, "Bronchiolitis"
Visiting Professor, Medical College of South Carolina, Charleston, SC - Grand Rounds,
"Idiopathic Pulmonary Fibrosis"
Visiting Professor, St. Joseph Hospital, Phoenix, AZ - Grand Rounds, "Hypersensitivity
Pneumonitis"
Invited Speaker, West Virginia Thoracic Society, Huntington, WV - "Idiopathic Pulmonary
Fibrosis"
Invited Speaker, American College of Chest Physicians, Boston, MA - Plenary Session,
Bronchiolitis"
Invited Speaker, American Thoracic Society, Boston, MA - Plenary Session, "Bronchiolitis"
Visiting Professor, Chubu Hospital, University of Hawaii, Okinawa, Japan - 5 lectures
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1990
Invited Speaker, Hawaii Thoracic Society, Honolulu, HI - "Idiopathic Pulmonary Fibrosis and
Small Airway Disease"
Invited Speaker, Division of Lung Disease, NIH Workshop Intervention in Idiopathic Pulmonary
Fibrosis, Washington D.C. - "Immune Complexes in Idiopathic Pulmonary Fibrosis"
Invited Speaker, American Thoracic Society, Boston, MA - Plenary Session, "Idiopathic
Pulmonary Fibrosis"
Visiting Professor, University of Michigan, School of Medicine, Ann Arbor, MI - Grand Rounds,
"Pathogenesis of Idiopathic Pulmonary Fibrosis"
Visiting Professor, New Jersey School of Medicine, Newark, NJ - Grand Rounds, "Bronchiolitis"
Invited Speaker, American College of Chest Physicians, Toronto, Canada - Plenary Session,
"Bronchiolitis Obliterans Organizing Pneumonia"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1991
Invited Speaker, American Thoracic Society, Anaheim, CA - Meet The Professor, "Update in
Interstitial Lung Disease"
Visiting Professor, Northeastern Ohio Universities College of Medicine, Canton, OH –
Grand Rounds, "Evaluation of the Patient with Interstitial Lung Disease"
Invited Speaker, Peruvian Society of Internal Medicine, Lima, Peru - Feature Speaker, "Updates in
Asthma, Vasculitis and Interstitial Lung Disease"
Invited Speaker, American College Chest Physicians, San Francisco, CA – Plenary Session,
"Evaluation of a Patient with Interstitial Lung Disease"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1992
Invited Speaker, Texas Thoracic Society, Austin, TX - Featured Speaker, "Alveolar Hemorrhage"
Invited Speaker, American Thoracic Society, Miami, FL - Plenary Session, "Bronchiolitis"
11
Visiting Professor, Yale University School of Medicine - Grand Rounds, "Idiopathic Pulmonary
Fibrosis"
Visiting Professor, University of California, San Francisco, CA - Speaker, "Diffuse Alveolar
Hemorrhage"
Visiting Professor, Morton Ziskind Memorial Lecture, Tulane University School of Medicine,
New Orleans, LA - "Diffuse Alveolar Hemorrhage"
Visiting Professor, Northwestern University School of Medicine, Chicago, IL - Grand Rounds,
"Idiopathic Pulmonary Fibrosis"
Invited Speaker, Chicago Thoracic Society, Chicago, IL - Featured Speaker, "Diffuse Alveolar
Hemorrhage"
Visiting Professor, Michael Reese Hospital, Chicago, IL - Grand Rounds, "Idiopathic Pulmonary
Fibrosis"
Visiting Professor, Walter Reed Army Hospital, Washington, D.C. - Grand Rounds, "Idiopathic
Pulmonary Fibrosis"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1993
Invited Speaker, American Thoracic Society, San Francisco, CA - Plenary Session, "Clinical Case
Presentations and Pro and Con, Should We Treat Idiopathic Pulmonary Fibrosis"
Visiting Professor, University of California, Los Angeles, CA - Grand Rounds, "Small Airways
Disease"
Invited Speaker, American College of Chest Physicians, Orlando, FL - Plenary Session,
Bronchiolitis"
Visiting Professor, Harvey Lecture, Northeastern Ohio Universities College of Medicine,
Youngstown, Ohio - "The Differentiation Between Obstructive and Restrictive Lung Disease
Pathophysiology"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO “Chest X-ray Interpretation"
1994
Invited Speaker, Tristate Thoracic Case Conference, Orange Beach, AL - "Small Airways Disease"
Invited Speaker, Annual Lecture of the Internal Medicine Group, New Orleans, LA - "Update in
Interstitial Lung Disease"
Invited Speaker, 50th Interstitial Lung Disease Conference, Tokyo, Japan - Idiopathic Pulmonary
Fibrosis in the USA"
Invited Speaker, Tri-State Consecutive Chest Conference, Jacksonville, FL - "Acute Interstitial
Pneumonia"
Invited Speaker, American College of Chest Physicians, New Orleans, LA - Plenary Session,
"Beyond Steroids: The Pharmacologic Management of Interstitial Lung Disease", "Year In
Review, Interstitial Lung Disease 1994"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1995
Invited Speaker, Gas Club, Milwaukee, WI - "Acute Interstitial Lung Diseases Update" St. Josephs
Hospital, Medical Grand Rounds, Milwaukee, WI "Bronchiolitis"
Invited Speaker, Academy of Allergy and Immunology, New York City, NY - "Approach to the
Diagnosis of Interstitial Lung Disease"
12
Invited Speaker, North Carolina Thoracic Society, Durham, NC - "Pharmacologic Management of
Interstitial Lung Disease and Acute Interstitial Lung Disease"
Visiting Professor, Memorial Hospital, Savannah, GA - "Update in Interstitial Lung Disease" and
"Diffuse Alveolar Hemorrhage"
Invited Speaker, Sino-American Pulmonary Critical Care Conference; Maui, Hawaii - "Pulmonary
Capillaritis and its Associations, and Bronchiolitis: The New Interstitial Lung Disease"
Invited Speaker, The Columbian Congress of Pneumonology; Bogata Columbia - "Update of
Interstitial Lung Disease", "Pulmonary Vasculitis", "Bronchiolitis", "Diffuse Alveolar
Hemorrhage" and "Pathology of Interstitial Lung Disease"
Visiting Professor, Mayo Clinic, "Acute Interstitial Pneumonia" - Rochester, MN
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
Invited Speaker, Recent Updates in Pulmonary and Critical Care Medicine, University of
California, San Francisco - "Acute Interstitial Lung Disease and Bronchiolitis"
Invited Speaker, American College of Chest Physicians, New York City, NY, Plenary Session "Acute Interstitial Lung Disease" and Review "Interstitial Lung Disease 1995"
1996
Visiting Professor, National Institutes of Health, Bethesda, MD, "Acute Interstitial Pneumonia"
Visiting Professor, Sam Sills Lecturer, American Lung Association of Los Angeles, Los Angeles,
CA, "Diffuse Alveolar Hemorrhage"
Visiting Professor, Harbor/UCLA, Los Angeles, CA - "Diffuse Alveolar Hemorrhage"
Visiting Professor, Cedars Sinai Medical Center, Los Angeles, CA - “Bronchiolitis"
Visiting Professor, University of Southern California, Los Angeles, CA - “Bronchiolitis"
Invited Speaker, American Thoracic Society, New Orleans, LA - "Interstitial Lung Disease Year in
Review" and Symposium "Pulmonary Hemorrhage"
Visiting Professor, University of Pittsburgh School of Medicine, Pittsburgh, PA - "Acute
Interstitial Pneumonia"
Visiting Professor, University of Texas Health Sciences Center, San Antonio, TX - "Acute
Interstitial Lung Disease"
Visiting Professor, Winthrop University Hospital, Long Island, NY - "Diffuse Alveolar
Hemorrhage"
Visiting Professor, State University of New York Health Science Center, Brooklyn, NY - "Acute
Interstitial Lung Disease"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Center for
Immunology and Respiratory Medicine, Denver, CO "Chest X-ray Interpretation"
1997
Visiting Professor, Southwestern School of Medicine, Dallas, TX - "Bronchiolitis"
Visiting Professor, St. Josephs Hospital, Phoenix, AZ - "Acute Interstitial Lung Disease"
Invited Speaker, 23rd meeting of Diffuse Panbronchiolitis, Tokyo, Japan "Diffuse Panbronchiolitis
in the USA", Ministry of Health and Welfare
Invited Speaker, 3rd Boehringer Ingelheim Annual Respiratory Workshop, Bangkok, Thailand,
"Interstitial Lung Disease", an update
Invited Speaker, Georgia Thoracic Society, Atlanta, GA - Symposium on "Interstitial Lung
Disease"
Invited Speaker, American Thoracic Society, annual meeting, San Francisco, CA - "Diffuse
Alveolar Hemorrhage"
Invited Speaker, 7th Congress of Lung Diseases, Sao Paulo, Brazil – "Bronchiolitis, Diffuse
13
Alveolar Hemorrhage, Pulmonary Vasculitis, Acute Interstitial Lung Disease"
Invited Speaker, Clinical Management and Control of Tuberculosis, National Jewish Medical and
Research Center, Denver, CO - "Chest X-ray Interpretation"
Invited Speaker, American College of Chest Physicians-Update in Pulmonary and Critical Care
Medicine, annual meeting, New Orleans, LA - "Interstitial Lung Disease"
Visiting Professor, Providence Portland Medical Center, Portland, OR - "Acute Interstitial Lung
Disease"
1998
Visiting Professor, Indiana University School of Medicine, The Sunnyside Guild lecturer;
Indianapolis, Indiana
Invited Speaker, American Thoracic Society, Annual Meeting, Chicago, IL – “DPLD Mimicking
Pneumonia – Idiopathic and Secondary BOOP and Acute and Chronic Eosinophilic
Pneumonia; Master Clinician; Fellows Cases; Presentation of Trudeau Medal
Invited Speaker, Pulmonary and Critical Care Geriatric Retreat, Interstitial Lung Disease, St.
Johns, Virgin Islands
Invited Speaker, American College of Chest Physicians – Interstitial Lung Disease, Year in
Review and Interactive Session, Toronto, Canada
Consultant to the UCLA Pulmonary and Critical Care Medicine Division Head, Search
Committee, Los Angeles, California
Visiting Professor, Federal University of Santa Catarina, International Symposium on Interstitial
Lung Disease, Flioranapolis, Brazil
1999
Visiting Professor, Stanford University, Update in Interstitial Lung Disease and Novel Therapies
for Pulmonary Fibrosis, Palo Alto, CA
Invited Speaker, New Jersey Thoracic Society, Acute Interstitial Pneumonia, New Brunswick,
New Jersey
Visiting Professor, Interstitial Lung Disease, Emory University, Atlanta, Georgia
Invited Speaker, American Thoracic Society, Fellows Symposium, San Diego, California
Visiting Professor, University of Vermont, Acute Interstitial Lung Disease, New Therapies for IPF,
Burlington, Vermont
Invited Speaker, Update in Pulmonary and Critical Care Medicine, Pulmonary Capillaritis and
Acute Interstitial Lung Disease, Ann Arbor, Michigan
Invited Speaker, Brazilian Pulmonary Congress, Overview of Interstitial Lung Disease,
granulomatous pulmonary vasculitis, bronchiolitis obliterans, idiopathic pulmonary
fibrosis: clinical classification and features; Treatment of idiopathic pulmonary fibrosis,
São Paulo, Brazil
Invited Speaker, Chilean Society of Respiratory Medicine, Diffuse Alveolar Hemorrhage,
Bronchiolitis, ILD in Connective Tissue Disease, Linares, Chile
Invited Speaker, American College of Chest Physicians, Interstitial Lung Disease – Year in
Review, Seek Board Review Course, Leadership Program
Invited Speaker, Mercy Hospital, 3rd Annual Fall Pulmonary Conference, Diffuse Alveolar
Hemorrhage, Charlotte, North Carolina
2000
Invited Speaker, Acute Interstitial Lung Disease, 44th Annual Tristate Thoracic Society Case
Conference, New Orleans, Louisiana
Invited Speaker, Symposium Acute Interstitial Lung Disease, American Thoracic Society, Toronto,
Canada
14
Invited Speaker, Oxygen Symposium, Sao Paolo, Brazil
Invited Speaker, Connecticut Thoracic Society, Alveolar Hemorrhage, New Haven, Connecticut
Invited Speaker, American College of Chest Physicians Meeting, Treatment of Interstitial Lung
Disease (Pro-Con), Plenary Session Diffuse Alveolar Hemorrhage, Board Review Cram
Course, Master Clinician, Leadership Program, IPF: Does Treatment work? The Wildest
Case I have ever Saw, San Francisco, California
Invited Speaker, Mercy Hospital, Annual Fall Pulmonary Conference, Diffuse Alveolar
Hemorrhage, Charlotte, North Carolina
Invited Speaker, Emerging Trends in Idiopathic Pulmonary Fibrosis, Dallas, Texas
Invited Speaker, Evening Grand Rounds, St. Luke’s Hospital, St. Louis, MO, “Novel Therapies in
IPF”
Visiting Professor, University of California, San Francisco, California – “Acute Interstitial Lung
Disease,” “Alveolar Hemorrhage Syndromes”
Visiting Professor, Medical College of South Carolina, Charleston, South Carolina –
“Pathogenesis and Treatment of IPF”
Visiting Professor, University of South Florida, Tampa, Florida – “Pathogenesis and Treatment of
IPF”
Visiting Professor, New York University School of Medicine, New York City, New York –
“Pathogenesis and Treatment of IPF”
2001
Invited Speaker, Lankenau Hospital, Grand Rounds, “New Concepts in IPF” Philadelphia,
Pennsylvania
Invited Speaker, American Thoracic Society, “Year in Review -- Interstitial Lung Disease,” PostGraduate course “Diffuse Alveolar Hemorrhage,” and symposium “New Concepts in
Diagnosis and Novel Treatments for Vasculitis,” “Master Clinician,” San Francisco,
California
Invited Speaker, Tri-State (Pembine) Conference, “Pathogenesis and Treatment of Idiopathic
Pulmonary Fibrosis,” Egg Harbor, Wisconsin
Invited Speaker, InterMune, “Future Treatment of Interstitial Lung Disease,” Las Vegas, Nevada
Invited Speaker, InterMune, “Novel Therapies for Idiopathic Pulmonary Fibrosis,” Palm Springs,
California
Invited Speaker, InterMune, Novel Therapies for Idiopathic Pulmonary Fibrosis, Orlando, Florida
Visiting Professor, Cleveland Clinic, “Pathogenesis of Idiopathic Pulmonary Fibrosis, Cleveland,
Ohio
Visiting Professor, Beth Israel Hospital, “Pathogenesis of Idiopathic Pulmonary Fibrosis,” New
York City, New York
Visiting Professor, St. Vincent’s Hospital, “The Idiopathic Interstitial Pneumonias: New Concepts
and Treatments” New York City, New York
Visiting Professor, Northwestern University School of Medicine, “Pathogenesis of Idiopathic
Pulmonary Fibrosis,” Chicago, Illinois
Visiting Professor, University of Michigan School of Medicine, “Bronchiolitis and Novel
Therapies in Idiopathic Pulmonary Fibrosis,” Ann Arbor, Michigan
Visiting Professor, Instituto de Enfermedades Respiratorias, “Acute Interstitial Lung Disease” and
“Subacute Interstitial Lung Disease,” Mexico City, Mexico
Visiting Professor, Medical College of South Carolina, “Pathogenesis of IPF,” Charleston, South
Carolina
15
Invited Speaker, American College of Chest Physicians, “Pulmonary Board Review Cram
Course,” “Interstitial Lung Disease – Radiographic, Histologic and Clinical Correlation,”
“Pulmonary Vasculitis: Evolving Concepts and Treatment of Vasculitis,” “Optimizing the
Management of the Patient with Idiopathic Pulmonary Fibrosis,” “Pathogenesis of
Idiopathic Pulmonary Fibrosis,” “Eosinophilic Lung Disease,” and “Chest Radiology for
the Pulmonologist.”
Visiting Professor, Ohio State University School of Medicine, “Fibroproliferation: A Novel Target
for Treatment of IPF.”
Invited Speaker, National Heart, Lung and Blood Institute, Working Group on Future Directions in
Pulmonary Fibrosis: “Heterogeneity in Pulmonary Fibrosis,” Bethesda, Maryland
Invited Speaker, Deborah Heart and Lung Center, Pulmonary Symposium, “Small Vessel
Vasculitis of the Lungs” and “Case studies in Interstitial Lung Disease,” Atlantic City, New
Jersey
Visiting Professor, Vanderbilt University School of Medicine, “Difficult Cases of Interstitial Lung
Disease,” Nashville, Tennessee
Visiting Professor, St. Thomas Vincent Hospital, Ohio Medical College, “Pathogenesis of
Idiopathic Pulmonary Fibrosis,” Toledo, Ohio
Visiting Professor, Long Island Jewish Hospital, “Pathogenesis and Treatment of Idiopathic
Pulmonary Fibrosis,” Long Island, New York
Visiting Professor, Harvard Medical School, “New Concepts in Pathogenesis and Novel
Treatments for Idiopathic Pulmonary Fibrosis,” Boston, Massachusetts
Visiting Professor, University of Oklahoma, “New Concepts in Pathogenesis and Novel
Treatments for Idiopathic Pulmonary Fibrosis,” Oklahoma City, Oklahoma
Visiting Professor, Columbia University School of Medicine, “New Concepts in Pathogenesis and
Novel Treatments for Idiopathic Pulmonary Fibrosis,” New York City, New York
Visiting Professor, University of Rochester School of Medicine, “New Concepts in Pathogenesis
and Novel Treatments for Idiopathic Pulmonary Fibrosis,” Rochester, New York
2002
The Stephan L. Kamholtz Visiting Professor, SUNY Health Science Center, Pathogenesis and
Treatment of Idiopathic Pulmonary Fibrosis, Brooklyn, New York
American Thoracic Society Annual Meeting – Diffuse Alveolar Hemorrhage, ILD Symposium,
Featured Speaker, “Toward the Conquest of Pulmonary Fibrosis,” Atlanta, Georgia
Visiting Professor, University of Cincinnati School of Medicine, “New Concepts in Pathogenesis
and Therapies for IPF,” Cincinnati, Ohio
Invited Speaker Royal Oak Hospital, “New Concepts in Pathogenesis and Therapies for IPF,”
Detroit, Michigan
Visiting Professor, IPF Colloquium, Mt. Sinai School of Medicine, “New Concepts in
Pathogenesis and Therapies for IPF,” New York, New York
Invited Speaker LAM Symposium, Keynote Address, “Smooth Muscle in Interstitial Lung
Disease,” Cincinnati, Ohio
Visiting Professor, Lahy Clinic, “Novel Therapeutic Approaches to IPF,” Burlingham,
Massachusetts
Visiting Professor, University of Oregon Health Sciences Center, “New Concepts in the
Pathogenesis of IPF,” Portland, Oregon
Visiting Professor, University of Pittsburgh School of Medicine, The Robert M. Rogers
Lectureship, “Novel Treatments for Idiopathic Pulmonary Fibrosis,” and “The Acute
Presentation of Interstitial Lung Disease,” Pittsburgh, Pennsylvania
16
Chairman and Speaker, Optimizing Therapy for Idiopathic Pulmonary Fibrosis Conference, Lake
Tahoe, Nevada
Presidential Citation and Lecture: “Pulmonary Fibrosis: I Think We Finally Have It Right,”
American College of Chest Physicians, San Diego, California
Invited Speaker, 1st Annual Pittsburgh International Lung Conference, “The Role of the
Myofibroblast in Idiopathic Pulmonary Fibrosis,” Nemacolin Woodlands Resort,
Pennsylvania
Visiting Professor, Louisiana State University School of Medicine, New Orleans, Louisiana
Invited Speaker, American College of Chest Physicians, “Pulmonary Board Review Cram Course”
and “Case Studies,” Symposium Chairman: “Treatment of Idiopathic Pulmonary Fibrosis,
“Master Clinician Session,” and “Chest Radiology for the Pulmonologist,” San Diego,
California
Invited Speaker, Chicago Thoracic Society, “Pathogenesis and Treatment of Idiopathic Pulmonary
Fibrosis,” Chicago, Illinois
Visiting Professor, Loyola University School of Medicine, Fellow Case Conference, Chicago,
Illinois
Visiting Professor, University of Illinois School of Medicine, Medical Grand Rounds, “The acute
interstitial pneumonias vs. ARDS,” Chicago, Illinois
Invited Speaker, Evening Grand Rounds, IFN-gamma in Idiopathic Pulmonary Fibrosis, St. Luke’s
Hospital, St. Louis, Missouri
Visiting Professor, University of Pennsylvania, “Small Vessel Vasculitis of the Lung,” Fellow
Case Conference, Philadelphia, Pennsylvania
Invited Speaker, Laennec Society of Philadelphia, “IPF-New Concepts in Pathogenesis,”
Philadelphia, Pennsylvania
Invited speaker, Genzyme Corporation, “Pathogenesis of Pulmonary Fibrosis,” Boston,
Massachusetts
2003
Invited Speaker, Washington Thoracic Society, “The Acute Presentation of Interstitial Lung
Disease,” and “Fibroproliferation and Therapy of IPF,” Seattle, Washington
Invited Speaker, Fibroproliferation in Interstitial Lung Disease, The John Butler Lung Conference,
Boise, Idaho
Visiting Professor, Duke University School of Medicine, “The Importance of the Myofibroblast in
Lung Fibrosis,” Durham, North Carolina
Invited Speaker, 17th Asia-Pacific Congress on Diseases of the Chest, “Imitators of ARDS”,
“Small Vessel Vasculitis of the Lung: Istanbul, Turkey
Invited Speaker, American Thoracic Society Annual Meeting, “Vasculitis in the Connective Tissue
Disease,” and Clinicopathologic Case Discussion Session, Seattle, Washington
Invited Speaker, Ohio Thoracic Society, “Pathogenesis of Pulmonary Fibrosis,” Toledo, Ohio
Visiting Professor, Henry Ford Hospital, “The ARDS Imitators,” Detroit, Michigan
Invited Speaker, American Thoracic Society Review Course – Update in Pulmonary Fibrosis and
Case Presentations, San Juan, Puerto Rico
Visiting Professor, Washington University, Grand Rounds, “Idiopathic Pulmonary Fibrosis: New
Concepts, Future Therapeutic Directions,” St. Louis, Missouri
Invited Speaker, American College of Rheumatology Review Course, “Management of pulmonary
fibrosis in the Connective tissue diseases,” Orlando, Florida
Invited Speaker, “Pathogenesis of Idiopathic Pulmonary Fibrosis,” Lake Lugano, Switzerland
17
Visiting Professor, Louisiana State University School of Medicine, “New Concepts in the
Pathogenesis of Idiopathic Pulmonary Fibrosis,” New Orleans, Louisiana
Visiting Professor, University of Oklahoma School of Medicine, “New Concepts in the
Pathogenesis of Pulmonary Fibrosis,” Oklahoma City, Oklahoma
Invited Speaker, University of Michigan, Update in Pulmonary and Critical Care Medicine Course,
“Imitators of ARDS” and “Pathogenesis of Idiopathic Pulmonary Fibrosis,” Ann Arbor,
Michigan
Visiting Professor, Nassau University Medical Center, Grand Rounds, “Imitators of ARDS,” and
“Pathogenesis of IPF,” East Meadow, New York
Invited Speaker and Chair, Satellite Symposium, “Pathogenesis of Idiopathic Pulmonary Fibrosis,”
American College of Chest Physicians Annual Meeting, Orlando, Florida
2004
Visiting Professor, Mt. Sinai School of Medicine, New York, New York
Visiting Professor, “The Acute Presentation of Interstitial Lung Disease,” Geffen School of
Medicine at UCLA, Los Angeles, California
Invited Speaker, American Thoracic Society - Review Course, “Updates in Pulmonary Fibrosis
and Case Presentation,” Washington, D.C.
Invited Speaker, American Thoracic Society International Meeting, “Fellow Case
Discussions” and plenary presentation “New Directions for Therapy of Idiopathic
Pulmonary Fibrosis,” and “Old and New Therapies for Idiopathic Pulmonary Fibrosis”
Invited Speaker, The John Butler Lung Conference, “Therapeutic Targets in IPF,” Boise, Idaho
Invited Speaker, American College of Chest Physicians, Vasculitis; Case Conference; Board
Review Course; “Unusual Presentations of Interstitial Lung Diseases,” Seattle, Washington
External Reviewer, Northwestern School of Medicine Pulmonary and Critical Care Medicine
Program, Chicago, Illinois
2005
Visiting Professor, “Idiopathic Pulmonary Fibrosis,” University College of Dublin, Dublin,
Ireland.
Invited Speaker, “Non-specific Interstitial Pneumonia,” Post-graduate Course and “Clinical Case
Studies,” American Thoracic Society, San Diego, California
Invited Speaker and Moderator, NHLBI Training Directors Meeting, San Diego, California
Visiting Professor, New York Methodist Hospital, “New concepts in Interstitial Lung Disease,”
New York City, New York
Visiting Professor, University of California, San Diego, “Pathogenesis of Pulmonary Fibrosis,”
San Diego, California.
Invited Speaker, NHLBI, Connective Tissue Associated Lung Disease Symposium, “Is Idiopathic
Pulmonary Fibrosis a connective tissue disease limited to the lung?” Cincinnati, Ohio.
Visiting Professor, Vanderbilt University School of Medicine, “Interstitial Lung Disease: Current
Evaluation and Emerging Treatment,” Nashville, Tennessee
Invited Speaker, “Interstitial pneumonia: a practical approach to management,” 1st Annual Lung
Health Management Conference, Henry Ford Hospital, Southfield, Michigan
Invited Speaker, The John Butler Lung Conference, “Newer Developments in the Pathogenesis
and Treatment of Pulmonary Fibrosis,” Boise, Idaho
Invited Speaker, American College of Chest Physicians, “Board Review,” Montreal, Canada
2006
Visiting Professor, Mt. Sinai School of Medicine, “The idiopathic interstitial pneumonias—new
concepts and therapeutic targets,” New York City, New York
18
Invited Speaker, ATS International Meeting, Vasculitis Symposium. “Vasculitis and the Lung
an overview and clinical evaluation” Discussant, “Fellows Case Symposium” Discussant
“Clinical Radiologic and Pathologic Correlations Master Clinician,” “Management of
Patients with Advanced IPF and Pulmonary Hypertension,” “Objectives, Organization and
operation of the LTRC,” San Diego, California
Invited Speaker, Pulmonary Update, “Presentation and Treatment of Vasculitis and Acute
Presentation of Interstitial Lung Disease,” University of Michigan, Ann Arbor, Michigan
Invited Speaker, The John Butler Lung Conference, Case discussions, Boise, Idaho
Invited Speaker and session Chairman, American College of Chest Physicians, Board Review,
Speaker Symposia: Rationalized Protocol for Advanced IPF, Salt Lake City, Utah
Invited Speaker, University of Cincinnati, Pulmonary and Critical Care Update, “Demystifying the
Interstitial Pneumonias and Diffuse Alveolar Hemorrhage,” Cincinnati, Ohio
2007
The William Parsons Visiting Professorship, University of Virginia, Charlottesville, Virginia
Invited speaker, ATS International Meeting, “Fellows Clinical Case Symposium, Clinical
Radiologic and Pathologic Correlations by Master Clinicians Meet the Professor” Chair
Diffuse Lung Disease and Acquisition and Use of Lung Tissues in Pulmonary Research,
Facilitator, Poster Session, IPF San Francisco, California
Invited Speaker, 2007 ATS State of the Art Course, “Lung Hemorrhage Syndromes”, Boston,
Massachusetts.
Invited Speaker, University of Kentucky, 3rd Annual Pulmonary and Critical Care Symposium;
Vasculitis, Lexington, Kentucky
Invited Speaker, Florida Society of Rheumatology, Interstitial Lung Disease in the Collagen
Vascular Disease, Sarasota, Florida
Invited Speaker, 16th Acute Interstitial Lung Disease, and an Alternative Approach to ILD Annual
Meeting of the Hellenic Thoracic Society, Interstitial Lung Disease, Athens, Greece
Invited Speaker, John Butler Lung Conference – ILD Update, Boise, Idaho
Invited Speaker, American College of Chest Physicians Annual Meeting, Chairman and Speaker
Board Preparation Course and Stump the Stars: Clinical/Radiologic/Pathologic case
reports, Chicago, Illinois
Invited Speaker, Pulmonary Symposium Cleveland Clinic, Management of IPF, Ft. Lauderdale,
Florida
2008
Invited Speaker, ATS Clinical State of the Art Course, Alveolar Hemorrhage Syndromes, Chicago,
Illinois
Invited Speaker, ATS International Meeting, “Fellows Clinical Case Symposium” and “Clinical,
Radiologic, Pathologic Correlations, Master Clinician”, “Year in Review, Interstitial Lung
Diseases”, Symposium, Clinical Characteristics of Individual Connective Tissue Diseases,
Toronto, Canada
Invited Speaker, American College of Chest Physicians Pro-Bono Course, Imitators of ARDS, the
Connective Tissue Diseases, Interstitial Pneumonias: A Different View, Buenos Aires,
Argentina
Invited Speaker, John Butler Lung Conference, Case Discussions, Boise, Idaho
Invited Speaker, American College of Chest Physicians, Board Review Course, Pulmonary,
Session Chair, Clinical Year in Review, and Discussant, Clinical Case Puzzlers, Nonidiopathic Interstitial Lung Disease
19
Invited Speaker, 15th Colloquium on Pulmonary Fibrosis, MuC5AC in Familial and Sporadic
Pulmonary Fibrosis, Sunset Beach, North Carolina
2009
Visiting Professor, “Continuing Controversies in Idiopathic Interstitial Pneumonias”, Royal
College of Physicians Ireland, Dublin, Ireland
Invited Speaker, A Different View of ILD, Pembine Conference, Egg Harbor, Wisconsin
Invited Speaker, 3rd Annual MaRP International Conference, “Unusual Vasculitis”, Modena, Italy
Invited Speaker and Discussant, American Thoracic International Conference, Fellows Case
Conferences; Great Cases Conference; Moderator Clinical Aspects of ILD and Clinical
Expert, Clinicians Center, Presenter Trudeau Medal, San Diego, California
Invited Speaker, American College of Chest Physicians, Co-Chair Mini-board Preparation Course,
San Diego, California
Invited Speaker, Pulmonary Vasculitis, Italian Society of Respirology, Milan Italy
Invited Speaker, The John Butler Lung Conference Continuing Controversies in the Interstitial
Pneumonias, Boise Idaho
2010
Invited Speaker, Duke University Pulmonary Fibrosis Symposium, Relationships of Connective
Tissue Disease to Pulmonary Fibrosis, Duke University, Durham, North Carolina
Invited Speaker, American Thoracic Society Conference: Discussant, Fellows Case Conference
and Great Case Conference; Discussant, Is this IPF: Something is trapped, podium
presentation MUC5AC polymorphism and outcome in IPF. Chairman, mini-symposium,
New Orleans, Louisiana
Invited Speaker, The John Butler Lung Conference, Genetics and Pulmonary Fibrosis, Boise,
Idaho
Invited Speaker, American College of Chest Physician, Interstitial Lung Disease, Unknown Cases,
Vancouver, Canada
2011
Invited Speaker, IPF Summit Pulmonary Fibrosis Foundation, From Bench to Bedside Treatment
Options, Case Presentations, Master Clinicians, Chicago Illinois.
Invited Speaker, American Thoracic Society Annual Conference, Fellows Case Conference, San
Francisco California, 2012
Invited Speaker, European Respiratory Society, From Alveolar Hemorrhage to Pulmonary Renal
Syndrome, Amsterdam, The Netherlands
Invited Speaker, and Discussant, American Thoracic Society, Fellows Case Conference and
Great Case Conferences, Denver, Colorado
Visiting Professor, Louisville University School of Medicine, Acute Interstitial Pneumonia and
Genetics of Pulmonary Fibrosis, Louisville, Kentucky
Invited Speaker, IPF Summit 2011, Pulmonary Fibrosis Foundation, Chicago, Illinois
Invited Speaker, The John Butler Lung Conference, Boise, Idaho
Invited Speaker, American Chest of Physicians, Annual Meeting, Clinical Case Puzzlers,
Interstitial Lung Disease, Honolulu, Hawaii
2012
Invited Speaker, American Thoracic Society, Annual Meeting, Fellows Case Conference and Great
Case Conferences, San Francisco, California
Invited Speaker, International Colloquium on Pulmonary and Airway Fibrosis, Modena, Italy
Invited Speaker, American Thoracic Society, Fibrosis Across Organ Systems, Denver, Colorado
20
HONORARY LECTURESHIPS:
Morton Ziskind Memorial Lecture, Tulane University, New Orleans, Louisiana 1992
The Harvey Lecture, Northwestern Ohio University College of Medicine 1993
The Sam Sills Lecturer, American Lung Association of Los Angeles, Los Angeles, California 1996
The Stephan Kamholtz Visiting Professor, SUNY Health Sciences Center, Brooklyn, NY, 2000
Presidential Citation and Lecture, The American College of Chest Physicians 2002
The William Parsons Visiting Professorship, University of Virginia, Charlottesville, Virginia,
2007
EDITORIAL POSITIONS:
Seminars in Respiratory Medicine: Associate Editor 1984 - 1996
American Thoracic Society, American College of Physicians, MKSAP 1 in the Subspecialty of
Pulmonary and Critical Care Medicine: Editorial Board 1991 - 1994
Chest: Editorial Board 1994 - 1999
American College of Chest Physicians, SEEK, Volume 5: Pulmonary Medicine, Editorial Board,
1994 - 1995
American College of Chest Physicians, SEEK, Volume 6: Critical Care Medicine, Editorial Board,
1995 - 1996
American College of Physicians and American Thoracic Society, MKSAP 2 in the Subspecialty of
Pulmonary Medicine and Critical Care: Editor 1996 - 1998
American College of Chest Physicians, SEEK, Volume 7: Pulmonary Medicine, Editorial Board
1996 - 1997
Pulmonary and Critical Care Medicine Update (PCCU): Editorial Board 1996 American College of Chest Physicians SEEK, Volume 8: Critical Care Medicine, Editorial Board
1997 – 1998
American College of Chest Physicians SEEK, Volume 9: Pulmonary Medicine, Editorial Board,
1998 – 1999
American College of Chest Physicians SEEK, Volume 10; Critical Care Medicine, Editorial
Board, 1999-2000
American College of Chest Physicians SEEK, Volume 11; Pulmonary Medicine, Editorial Board,
2000-2001
American College of Chest Physicians SEEK, Volume 12; Critical Care Medicine, Editorial
Board, 2001-2002
MD Consult-On-Line, Editorial Advisory Board, Respiratory and Critical Care Medicine 20012003
American College of Chest Physicians SEEK, Volume 13; Pulmonary Medicine, Editorial Board,
2002-2003
American College of Chest Physicians, SEEK, Volume 14; Critical Care Medicine, 2003-2004,
Editorial Board
American College of Chest Physicians, SEEK, Volume 15; Pulmonary Medicine 2004-2005,
Editorial Board
Chest, Associate Editor and Section Editor for Case Records of the University of Colorado 2003Member Ethics Committee, and Member CME Committee , 2005American College of Chest Physicians SEEK, Volume 16; Critical Care Medicine
2005-2006, Editorial Board
Editorial Board, International Journal of Chronic Obstructive Lung Disease 2005Editorial Board, Faculty of 1000 Medicine, Respiratory Disorders
21
American College of Chest Physicians SEEK, Volume 17; Editorial Board Pulmonary Disease
2006-2007
Editorial Board, The Open Respiratory Medical Journal, Bentham Science Publishers, 2007Honorary Editorial Board, Clinical Medicine: Respiratory and Pulmonary Medicine, 2007
Honorary Editorial Board, The International Journal of General Medicine, 2008Honorary Editorial Board, International Medical Case Reports Journal, 2009Editorial Board, Pulmonary Medicine online Journal, 2009Editorial Board, Clinical Medicine Insights: Circulatory Respiratory and Pulmonary Medicine
2012
JOURNAL REVIEW ACTIVITIES:
Chest
American Journal of Respiratory and Critical Care Medicine
Annals of Internal Medicine
American Journal of Medicine
Archives of Internal Medicine
Respiratory Medicine
Lancet
Journal of Laboratory and Clinical Medicine
Arthritis and Rheumatism
Southern Medical Journal
Gastroenterology
European Respiratory Journal
American Journal of Medical Science
Journal of Medical Genetics
American Journal of Respiratory Cell and Molecular Biology
Respiration Physiology
Clinical Rheumatology
Expert Opinion on Pharmacotherapy
Journal of Critical Illness
American Journal of Pathology
Journal of the American Medical Association
Thorax
Biomedical Medical Central – Pulmonary Medicine
Pediatric Pulmonology
Respiratory Research
Mayo Clinic Proceedings
Drug Safety
PLoS Medicine
Open Respiratory Medical Journal
Current Respiratory Medicine Reviews
Respirology
Case Reports in Medicine
New England Journal of Medicine
Experimental Lung Research
Advances in Therapy
22
GRANT REVIEW:
Veterans Administration Merit Review 1998
National Institute of Environmental Health Sciences 1999
National Heart, Lung, and Blood Institute Research Training Grant Review Committee (Ad Hoc),
1998
University of Leuvin, Belgium, 1999
National Institutes of Health, National Center for Research Resources, 2000
National Institutes of Health, GCRC Grant Review and Site Visit, 2000
Philip Morris External Research Program, 2003
Canadian Lung Association, 2004 - 2005
American Thoracic Society Scientific Review Committee (ad hoc), 2006 National Institutes of Health, Fellowship Scientific Review Group, Health of the Population
Integrated Review Group, 2006 – 2008
National Heart, Blood and Lung Institute, Special Emphasis Panel, Small Grants for Lung Tissue
Research, 2008
University of Colorado, Member, Bridge Funding, Review Panel, 2008 –
National Institute of Health, National Center for Research Resources, Clinical Research
Curriculum Award (R30) Review Panel, 2009
Eternal Advisory Committee NHLBI T32 Pulmonary Training Program, University of Texas
Southwestern School of Medicine 2009 – 2014 and Tulane University School of Medicine
2009 - 2014
CURRENT EXTRAMURAL FUNDING:
Principal Investigator 2 T32HL007085, NHLBI Research Service Award, Multidisciplinary
Respiratory Disease Research 1987-2015
Co-Investigator IU1OHl074409, Novel Strategies Targeting Acute Exacerbations of COPD,
2003-2009
Chair, Steering Committee, NHLBI 1U10HL80590, Idiopathic Pulmonary Fibrosis Clinical
Research Network, 2011-2014
Principal Investigator, University Site, (Albert PI) N01-HR-76185, Long term Oxygen Treatment
Trial (LOTT), 2006 – 2012
Co-Investigator (D. Schwartz, PI) NHLBI – R01HL095393-01 Genomic Signatures for Idiopathic
Interstitial Pneumonia 2008-2013
Co-Investigator (D. Schwartz PI) NHLBI R01-HL097163 GWAS in Pulmonary Fibrosis 20092014
Co-Investigator Core B 1P01 HL092870-01A1 Mechanism of Familial Pulmonary Fibrosis (T.
Blackwell PI) 2009 – 2014
PENDING GRANTS
Co-Principal Investigator, NHLBI RO1, Beyond Linkage and GWAS in Pulmonary Fibrosis, D.
Schwartz PI, 2012 – 2017
RECENT COMPLETED GRANTS
Principal Investigator, NO-1-HR46160, NHLBI Lung Tissue Research Consortium, Clinical
Center, 2004-2010
Principal Investigator, NO-1-HR46160, VEGF in the pathogenesis of IPF and Emphysema,
NHLBI Lung Tissue Research Consortium Clinical Center, 2005-2009
23
Co-Investigator For NHLBI 1010HL80590, Idiopathic Pulmonary Fibrosis Clinical Research Net
Work 2005-2011
Co-Investigator IRC2HL10713-01, Lung Genomic Research Consortium, Geraci, Schwartz (PI’s)
2009-2011
PATENTS:
Steele M, Speer M, Schwartz D, Burch L, Herron A, Schwarz MI, Brown K, Loyd J. The
identification of a susceptibility gene for familial interstitial pneumonitis on chromosome
10. (Pending)
Schwartz D, Steele M, Speer MC, Burch L, Brown K, Schwarz MI, Lloyd J. Mutations in mucin
genes cause pulmonary fibrosis.
PUBLICATIONS:
I.
PEER REVIEWED PAPERS
1.
Weill H, George R, Schwarz MI, et al: Late evaluation of pulmonary function after acute exposure
to chlorine gas. Am Rev Respir Dis 1969; 99:374
Schwarz MI, Waddell LC, Dombeck DH, et al: Prolonged survival in lymphangitic
carcinomatosis. Ann Intern Med 1969; 71:779
Ziskind MM, Schwarz MI, George R, et al: Incomplete consolidation in pneumococcal lobar
pneumonia complicating pulmonary emphysema. Ann Intern Med 1970; 72:835
Whitcomb ME, Schwarz MI, Charles M, et al: Interstitial fibrosis after pneumocystis carinii
pneumonia. Ann Intern Med 1970; 73:761
Schwarz MI, Whitcomb ME, French J: Significance of an isolated reduction of the residual
volume. Am Rev Respir Dis 1971; 103:430
Whitcomb ME, Schwarz MI: Pleural effusion complicating mediastinal radiation. Am Rev Respir
Dis 1971; 103:100
Schwarz MI, Goldman AL, Roycroft DW, et al: Vascular invasion of chrondrosarcoma
simulating pulmonary emboli. Am Rev Respir Dis 1972; 106:109
Whitcomb ME, Schwarz MI, Keller AR, et al: Hodgkin’s disease of the lung. Am Rev Respir Dis
1972; 106:79
Charles M, Hildebrandt PK, Schwarz MI: Pulmonary effects of pentamidine. Ann Intern Med
1972; 76:144
Whitcomb ME, Schwarz MI, Tormey D: Methotrexate pneumonitis. Thorax 1972; 27:636
Schwarz MI, Whitcomb ME, Goldman AL: The spectrum of diffuse pulmonary infiltration in
malignant disease. Chest 1973; 64:88
Goldman AL, Bramen S, Schwarz MI: Steroid responsive hypercalcemia in disseminated bone
tuberculosis. Arch Intern Med 1973; 132:269
Sahn S, Schwarz MI, Lakshminarayan S: Sarcoidosis: The significance of an acinar pattern on
chest roentgenogram. Chest 1974; 65:684
Sahn S, Schwarz MI: Desquamative interstitial pneumonia with a normal chest roentgenogram.
Brit J Dis Chest 1974; 68:228
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
24
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
Goodman RL, Hazlett DR, Bergin JJ, Flannery EP, Schwarz MI: Sickle cell trait and loss of
pulmonary function at 5,280 feet and sea level. Thrombosis et diathesis haemorrhagica 1974;
53:91
Schwarz MI, Marmorstein B: A new radiographic sign of sub-pulmonic effusion. Chest 1975;
67:176
Schwarz MI, Marmorstein B: A radiographic sign of left-sided mediastinal lymph node
enlargement. Chest 1975; 68:116
Matthay R, Schwarz MI, Petty TL, et al: Acute lupus pneumonitis: Analysis of twelve cases.
Medicine (Baltimore) 1975; 54:397
Schwarz MI, Matthay RA, Sahn SA, et al: Interstitial lung disease in polymyositis and
dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976;
55:89
Lakshminarayan S, Schwarz MI, Stanford RE: Unsuspected pulmonary alveolar proteinosis
complicating acute myelogenous leukemia. Chest 1976; 69:433
Levin DC, Schwarz MI, Matthay RA, LaForce FM: Bacteremic hemophilus pneumonia in adults.
Am J Med 1977; 62:219
Scoggin CH, Schwarz MI, Dixon BW, Durrance JR: Tuberculosis of the skull. Arch Int Med
1976; 136:1154
Schwarz MI: Pulmonary lymphangitic carcinomatosis. Chest 1976; 70:105
Iseman MD, Schwarz MI, Stanford RE: Angioimmunoblastic lymphadenopathy with
dysproteinemia with lung involvement: A case report with immunofluorescent staining of lung
tissue. Ann Intern Med 1976; 85:752
Good J, Schwarz MI, Seibert PE: Posterior tracheal stripe sign. Chest 1976; 71:322
Kaehny W, Schwarz MI, McIntosh RM, et al: Post-Pneumococcal immune glomerulonephritis
and alveolitis. Arch Int Med 1978; 138:806
Schwarz MI, Dreisin RB, Pratt DE, Stanford RE: Immunofluorescent patterns in the idiopathic
interstitial pneumonias. J Lab Clin Med 1978; 91:929
Dreisin RB, Schwarz MI, Theophilopoulos AN, Stanford RE: Circulating immune complexes in
the idiopathic interstitial pneumonias. New Engl J Med 1978; 298:353
May JJ, Schwarz MI, Dreisin RB: The occurrence of idiopathic thrombocytopenic purpura in
diffuse interstitial lung disease. Ann Intern Med 1979; 90:199
King TE, Schwarz MI, Dreisin RB, Pratt DS, Theofilopoulos AN: Circulating immune complexes
in pulmonary eosinophilic granuloma. Ann Intern Med 1979; 91:397
Pratt DS, Katulis J, Dreisin RB, Robinson HM, Schwarz MI: The use of fluorescent labeled
antigen to follow the fate of instilled immune complexes in the rabbit lung. J Immunol Methods
1979; 27:127
Pratt DS, Schwarz MI, May JJ, Dreisin RB: Rapidly fatal pulmonary fibrosis: The accelerated
variant of interstitial pneumonitis. Thorax 1979; 34:587
Matthay RA, Schwarz MI, Ellis JH, et al: Pulmonary artery hypertension in chronic obstructive
pulmonary disease: Determination by chest radiography. Invest Radiol 1981; 16:95
King TE, Fisher L, Schwarz MI: Asymptomatic symmetrical pulmonary hilar adenopathy. An
unusual presentation of renal cell carcinoma. Thorax 1982; 37:317
King TE, Christopher KL, Schwarz MI: Multiple pulmonary chrondromatous hamartomas.
Human Pathology 1982; 13:496
Heffner JE, Duffey DJ, Schwarz MI: Massive pleural effusion from prostatic lymphangitic
carcinomatosis: Resolution with endocrine therapy. Arch Int Med 1982; 142:375
25
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
Shasby DM, Schwarz MI, Stanford RE, et al: Immune complex deposition in Wegener’s
granulomatosis. Chest 1982; 81:338
King TE, Schwarz MI, Mathew M: Waldenstroms macroglobulinemia J Nat Med Assos 1984;
76:184
Libby LS, King TE, LaForce FM, Schwarz MI: Pulmonary cavitation following pulmonary
infarction. Medicine 1985; 64:342.
Watters LC, King TE, Cherniack RM, Waldron J, Stanford RE, Christopher KL, Schwarz MI:
Bronchoalveolar lavage neutrophil content increases after corticosteroid therapy in smokers with
idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133:104
Watters LC, King TE, Schwarz MI et al: A clinical, radiographic and physiologic scoring system
for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis
1986; 133:97
Watters LC, Schwarz MI, Cherniack RM, et al: Idiopathic pulmonary fibrosis. Pretreatment
bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and
clinical response to therapy. Am Rev Respir Dis 1987; 135:696
Morrison DA, Adcock K, Collins CM, Goldman S, Caldwell JH, Schwarz MI: Right ventricular
dysfunction and the exercise limitation of chronic obstructive lung disease. J Am Coll Cardiol
1987; 9:1219
Dunn TL, Watters LC, Hendrix C, Cherniack RM, Schwarz MI, King TE: Gas exchange at a
given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis.
Am J Med 1988; 85:221
Badesch DB, King TE, Schwarz MI: Acute eosinophilic pneumonia: a hypersensitivity
phenomenon? Am Rev Respir Dis 1989; 139:249
Aguayo SM, Kane MA, King TE, Schwarz MI, Grauer L, Miller YE: Increased bombesin like
peptide in the lower respiratory tract of asymptomatic cigarette smokers. J Clin Invest 1989;
84:1105
Badesch DB, McClellan M, Wheeler A, Archer P, Schwarz MI, Petty T: A model for the objective
assessment of clinical training programs: The initial application to two pulmonary fellowship
programs. Am Rev Respir Dis 1989; 140:1136
Leff JA, Ready RB, Repetto C, Goff JS, Schwarz MI: Coexistence of primary biliary cirrhosis
and sarcoidosis. Review of the Literature. West J Med 1990; 153:439
The BAL Co-operative Steering Committee: Bronchoalveolar lavage constituents in healthy
individuals, idiopathic pulmonary fibrosis and selected comparison groups. Am Rev Respir Dis
1990; 141:S169
Hanley ME, King TE, Schwarz MI, et al: The impact of smoking on mechanical properties of the
lungs in idiopathic pulmonary fibrosis and sarcoidosis. Am Rev Respir Dis 1991 144: 1102-1106
Walker SR, Schwarz MI, Wallace ME, et al: Pathogenesis of interstitial lung disease: an
immunoelection microscopic study. Am Rev Respir Dis 1991
Kulwiec E, Lynch D, Aguayo S, Schwarz MI, King TE, Jr.: Imaging of pulmonary histocytosis X.
Radiographics 1992; 12:515-526
Schwarz MI, Colby TV, Lynch DA, Waldron J, Mortenson RL, Hutt MP, Cherniack RM, King
TE, Jr.: Pulmonary Capillaritis: the association with progressive airflow limitation and
hyperinflation. Am Rev Respir Dis 1993; 148:507-511
Schwarz MI: Acute non-infectious diffuse interstitial pneumonitis in a 45-year-old woman. Chest
1993; 104:927-929
26
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
Chen IY, Lynch DA, Shroyer KR, Schwarz MI: Gaucher Disease: An unusual cause of
intrathoracic extramedullary hematopoiesis. Chest 1993; 104:1923-1924
Moss M, Neff TA, Colby T, Schwarz MI, Zamora M: Diffuse alveolar hemorrhage due to
antibasement membrane antibody disease appearing with a polyglandular autoimmune syndrome.
Chest 1994; 105:296-298
Schwarz MI, Lynch DA, Tuder R: Bronchiolitis obliterans: the presenting manifestation of
rheumatoid arthritis? Eur Respir J 1994; 7:817-820
Schwarz MI, Sutarik JM, Nick J, Leff JA, Emlen WE, Tuder RM. Pulmonary capillaritis and
diffuse alveolar hemorrhage: A primary manifestation of polymyositis. Am J Respir Crit Care
Med 1995; 151:2037-2040
Cherniack RM, Colby TV, Flint A, Thurlbeck WM, Waldron JA, Ackerson I, Schwarz MI, King
TE: Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care
Med 1995; 151:1180-1187
Chan E, Terada L, Schwarz MI: The occurrence of sarcoidosis in sickle cell disease. J Nat Med
Assoc 1995; 87:826-828
Fitzgerald J, Tuder RM, Lynch DA, King TE, Schwarz MI: Diffuse panbronchiolitis in the United
States. Am J Respir Crit Care Med 1996; 154:497-503
Jennings CE, Tuder R, Cherniack RM, King TE, Schwarz MI: Diffuse alveolar hemorrhage with
underlying isolated pauci-immune pulmonary capillaritis. Am J Respir Crit Care Med 1997;
155:1101-1109
Tuder RM, Cool C, Jennings C, King TE, Schwarz MI, Voelkel NF: The morphological and
cellular basis for pulmonary vascular disease in interstitial lung disease: a perspective, Submitted
Zamora MR, Warner ML, Tudor R, Schwarz MI: Diffuse alveolar hemorrhage and systemic lupus
erythematosus (SLE): Clinical Presentation, Histology, Survival and Outcome. Medicine 1997;
76:192-202.
Badesch DB, Zamora MR, Fullerton D, Weill D, Tuder R, Grover F, Schwarz MI: Pulmonary
capillaritis: A histologic form of acute lung allograft rejection. J Heart Lung Transpl 1998;
17:415-422.
Bowler R, Durham J, Schwarz MI: Massive hemoptysis from a pulmonary artery aneurysm
associated with an emphysematous bulla. Chest 1998; 113:1130-1131.
Schwarz MI, Zamora ME, Hodges T, Chan E, Bowler R, Tuder RM: Isolated capillaritis and
diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest
1998; 113:1609-1615.
Nicolls MR, Terada L, Tuder RM, Prindiville S, Schwarz MI: Diffuse alveolar hemorrhage and
pulmonary capillaritis in the retinoic acid syndrome. Am J Resp Crit Care Med 1998; 158:13021305.
Chan ED, Kalayanamit T, Lynch DA, Arndt P, Tuder R, Winn R, Schwarz MI. Mycoplasma
pneumoniae-associated bronchiolitis causing severe restrictive lung disease in adults: report of
three cases and literature review. Chest 1999; 115:1188-1194
Nick JA, Lynch D, Schwarz MI, Hanley ME. Chest pain as a complication of hereditary multiple
exostosis. Respiratory Medicine, 1999; 213-216.
Mason R, Schwarz MI, Hunninghake G, Musson R. Pharmacologic therapy for idiopathic
pulmonary fibrosis: past, present and future. Am J Resp Crit Care Med 1999; 160:1771-1777.
Winn RA, Stoeckli TC, Wilson ML, Burman W, Schwarz MI. Multiple pulmonary nodules in an
HIV positive man on highly active antiretroviral therapy. Chest 2002; 122:1840-1843.
27
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
Glazer C, Cohen L, Schwarz MI. Acute eosinophilic pneumonia in the acquired
immunodeficiency syndrome. Chest 2001; 120:1732-1735.
Dhillon SS, Singh D, Doe M, Oadri AM, Ricciardi S, Schwarz MI. Diffuse alveolar hemorrhage
and pulmonary capillaritis due to propylthiouracil. Chest 1999; 116:1485-1488.
King TE, Schwarz MI, Brown K, Tooze JA Colby TV, Flint A, Waldron J, Thurlbeck W,
Cherniack RM. Idiopathic pulmonary fibrosis: relationship between histopathologic features and
mortality. Amer J Respir Crit Care Med 2001; 164:1025-1032.
King TE, Tooze JA, Brown KK, Lynch D, Schwarz MI, Cherniack RM. Predicting survival in
idiopathic pulmonary fibrosis: clinical scoring system and survival model. Am J Respir Crit Care
Med 2001; 164:1171-1181.
Brown KK, Morales DV, King TE, Schwarz MI. Desquamative interstitial pneumonia:
comparison to usual interstitial pneumonia/idiopathic pulmonary fibrosis. Submitted
Vourlekis JS, Brown KK, Cool C, Cherniack RM, King TE, Schwarz MI. Acute interstitial
pneumonitis: initial presentation and subsequent course. Medicine 2000; 79:369-378.
Fouty B, Lynch D, Schwarz MI. Hypoxemia explained 36 years later. Chest 2001; 120:1739-1740.
Markopoulou KD, Cool CD, Elliot TL, Lynch DA, Newell JD, Hale JA, Brown KK, Schwarz MI,
Tuder RM. Obliterative bronchiolitis: varying presentations and clinicopathologic correlations. Eur
Respir J 2002; 19:20-30.
Vourlekis JS, Schwarz MI, Cool CD, Tuder RM, King TE, Brown KK. Non-specific interstitial
pneumonitis: the sole histologic expression of hypersensitivity pneumonitis. Am J Med 2002;
112:490-493.
Chan E, Morales DV, Welsh C, McDermott MT, Schwarz MI. Diffuse lung parenchymal
calcification and bone formation. Am Rev Respir Crit Care Med, 2002; 165:1654-1669.
Crystal RA, Bitterman P, Mossman B, Schwarz MI, et al. Future directions in idiopathic
pulmonary fibrosis: Summary of a National Heart, Lung and Blood Institute Working Group. Am J
Respir Crit Care Med 2002; 166:236-246.
Vourlekis JS, Schwarz MI, Cherniack RM, Curran Everett ED, Cool CD, Tuder RM. King TE, Jr.,
Brown KK. The impact of pulmonary fibrosis on survival in hypersensitivity pneumonitis. Am J
Resp Crit Care Med 2004; 116:662-668
Collard HR, King TE Jr., Bartelson BB, Vourlekis JV, Schwarz MI, Brown KK. Changes in
clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Resp
Crit Care Med 2003; 168:532-538.
Schwarz MI, Albert RK. Imitators of the acute respiratory distress syndrome: implications for
diagnosis and treatment. CHEST 2004; 125:1530-1535.
Collard HR, Ryu JH, Douglas WW, King TE, Schwarz MI, Curran-Everett D, Brown KK.
Corticosteroid and cytotoxic therapy does not improve survival in idiopathic pulmonary fibrosis.
CHEST 2004; 125:2169-2179
Cosgrove GP, Brown KK, Scheimann WP, Serls A, Parr J, Geraci MW, Schwarz MI, Cool CD,
Worthen GS. Pigment epithelium-derived growth factor in idiopathic pulmonary fibrosis: a role in
aberrant angiogenesis. Am J Resp Crit Care Med 2004; 110:242-251.
Fessler NB, Cool DC, Miller YE, Schwarz MI, Brown KK. /Brief Report: Idiopathic Diffuse
Hyperplasia of pulmonary neuroendocrine cells and acromeagly. Respirology 2004; 9: 274-277
Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, Slifer SH, Burch LH, Phillips III JA, Sporn
TA, McAdams HP, Schwarz MI and Schwartz DA. The clinical and pathologic features of
familial interstitial pneumonia (FIP). Am J Resp Crit Care Med 2005; 172:1140-1146.
28
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
Shah NR, Nobel P, Jackson RM, King TE, Nathan SO, Padilla M, Raghu G, Rhodes MB, Schwarz
MI, Tino G, Dubois RW. A critical assessment of treatment options for idiopathic pulmonary
fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:167-174.
Astor TL, Weill D, Cool C, Teitelbaum I, Schwarz MI, Zamora MR. Pulmonary Capillaritis in
Lung Transplant Recipients. Treatment and Affect on Allograft Function. Journal of Heart and
Lung Transplant 2005; 24: 2091-2097
Collard HR, Tino G, Shreve MA, Carlson B, Noble P, Michaels M, Schwarz MI. Results of a
patient survey regarding the management of idiopathic pulmonary fibrosis. Respir Med, 2007; 101:
1350-1354
Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK. Lymphoid interstitial pneumonia:
clinical features, associations and prognosis. Eur Resp J 2006; 364-369
Steele MP, Speer MC, Loyd JC, Brown KK, Herron A, Slifer SH, Burch LH, Wahidi M, Phillips
JA, Sporn TA, McAdams HP, Schwarz MI, Schwartz DA. The role of genetics and cigarette
smoking in the development of pulmonary fibrosis. Respirology 2006; Jan 11, 1:
Yang IV, Burch LH, Steele MP, Savor JD, Hollingsworth JW, McElvania-Tekippe E, Berman KG,
Speer MC, Sporn TA, Brown KK, Schwarz MI, Schwartz DA. Gene expression profiling of
familial and sporadic cases of interstitial pneumonia. Am J Respir Crit Care Med 2007; 175: 4554
Portnoy J, Veraldi KL , Schwarz MI, Cool CA, Current-Everett D, Cherniack RM, King TE,
Brown KK. Respiratory bronchiolitis—Interstitial lung disease: long term outcome. Chest 2007;
131: 664-671.
Collard HR, Anstrom KJ, Schwarz MI, Zisman DA. Sildenafil improves walk distance in patients
with idiopathic pulmonary fibrosis and pulmonary arterial hypertension. Chest 2007; 131: 892899.
Hope-Gill B, Cool CD, Hakan S, Lynch DA, Schwarz MI, Brown KK. Primary Sjögren’s
syndrome-related interstitial lung disease: clinical features, histopathology and outcome.
Submitted.
Wise AL, Speer MC, Burch LH, Steele MP, Herron A, Loyd JE, Brown KK, Phillips J, Slifer SH,
Schwarz MI, Schwartz DA. Evidence of significant linkage to chromosome 10 in familial
interstitial pneumonia. In Press
Hunninghake GW, Schwarz MI. A Perspective: Does current knowledge explain the
pathogenesis of idiopathic pulmonary fibrosis? Proc Am Thorac Soc. 2007; 4:449-452
Ezzie M, Janssen WJ, O’Brien JM, Fox C, Schwarz MI. Clinical Problem Solving: Failure to
Respond. N. Engl J Med 2008; 538: 70-74
Kinder BW, Brown KK, Schwarz MI, Ix JH, Kervitsky A, King TE. Baseline Bronchoalveolar
Lavage Neutrophilia Predicts Early Mortality in Idiopathic Pulmonary Fibrosis. Chest 2008; 133:
226-232
Zisman DA, Karlamangla AS, Kawut SM, Shlobin OA, Sagger R, Schwarz MI, Belpario VA,
Lynch JP, Nathan SD. Validation of a New Method to Predict the Presence of Pulmonary
Hypertension in Advanced Idiopathic Pulmonary Fibrosis. Chest 2008; 133: 640-645
Collard HR, Moore BB, Flaherty JR, The idiopathic pulmonary fibrosis clinical research network
investigators, et al. Acute Exacerbations of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care
Med 2007: 176: 636-643
Olson AL, Huie T, Schwarz MI, Brown KK, Frankel SK, Acute Exacerbations of Fibrotic
Hypersensitivity Pneumonitis. Chest 2008; 134:844-850
29
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
Zisman DA, Kawot SM, Belpario JA, Lynch DP, Schwarz MI, Tayek JA, Reuben DBm
Karlamangla AS: Serum Albumin Concentration and Mortality in Idiopathic Pulmonary Fibrosis.
Chest 2009: 155: 929-935
Kinder BW, Brown KK, McCormick FX, Ix JH, Kervitzky A, Schwarz MI, King TE: Baseline
Serum Surfactant Protein A is a Strong Predictor of Early Mortality in Idiopathic Pulmonary
Fibrosis. Chest 2009; 135: 1557-1563
Han ML, Bartholomei B, Curtis JL, Sciurba F, Thompson B, Frederick M, Schwarz MI, Limper
A, Fredman C, Martinez F: Clinical Significance of radiologic characterizations in COPD.
J.COPD 2010; 6: 454 - 467
Speer MC, Burch LH, Wise AL, Steele MP, Herron A, Loyd JE, Brown KK, Phillips JA, Slifer H,
Potocky C, Sporn TA, McAdams P, Schwarz MI, Schwartz DA. Familial Interstitial Pneumonia
is linked to Chromosomes. 10,11,12 submitted
Boon K, Bailey NW, Yang I, Kervitsky D, Brown KK, Schwarz MI, Schwartz DA. Molecular
phenotypes distinguish patients with relatively severe from progressive idiopathic pulmonary
fibrosis. PLosONE 2009; 4: e5134
Wise AL, Speer MC, Steele MP, Burch LH, Herron A, Brown RK, Slifer SH, Sporn TA,
McAdams P, Schwarz MI, Schwartz DH. Linkage to chromosome 10 in familial interstitial
pneumonia (FIP) demonstrates that FIP is a complex disease. Submitted
Huie TJ, Olson AL, Cosgrove GP, Janssen WJ, Lynch DA, Groshong SD, Schwarz MI, Brown
RK, Frankel SK. Acute respiratory decline in patients with fibrotic lung diseases. Respirology
2010; 15:909-917.
Han ML, Bartholomai B, Frederick M, Schwarz MI, Limper A, Martinez FJ. Gender Influences
Health Related Quality of Life in IPF. Respir Med 2010; 104: 724-730.
Stoller JK, Ramos RJ, Krackman S, Doherty DE, Make B, for the Long-Term Oxygen Therapy
Trial (LOTT). Oxygen therapy for patients with COPD: Current evidence and the long-term
oxygen treatment trial (LOTT). Submitted
Zisman DA, Schwarz, MI, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW. For the
Idiopathic Pulmonary Fibrosis Treatment Network Investigators, Member of the Protocol and
Writing Committees . A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary
Fibrosis. N Engl J Med 2010; 363: 620-628.
Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W,
Gudmundsson, Groshong SD, Evans CM, Garamtziotis S, Adler KB, Dickey BF, Du Bois RM,
Yang IV, Herron A, Kervitsky D, Talbert JL, Markin C, Zhang L, Park J, Crews AL, Slifer SH, Xu
H, Potocky CH, Auerbach S, Masinde T, Roy MG, Jancewicz JM, Lin J, Hennessey CE, Schwarz,
MI, Schwartz, DA. Common Polymorphism in MUC5B Promoter is a Risk Factor for the
Development of Familial Interstitial Pneumonia (FIP) and Idiopathic Pulmonary Fibrosis (IPF). N
Engl J Med. 2011; 364: 1503-1512.
Berry CE, Durmmonda MD, Han MK, Danen L, Fuller C, Limpec AH, Martinez FJ, Schwarz MI,
Sciruba FC, Wise RA. Relationship Between Heath Quality of Life and Lung Function in COPD
and ILD. In Press
Yang E, Luna LG, Yang I, Cotter J, Talbert J, Leach S, Kidd R, Turner J, Kummer N, Kervetsky
D, Brown K, Boone K, Schwarz M, Schwartz D, Steele M. The Peripheral Blood Transcriptome
Identifies the Extent and Severity of Disease in Idiopathic Pulmonary Fibrosis – Submitted.
Lee HY, Seo JB, Wise AI, Kluiber A, Steele MP, Brown KK, Loyd LL, Talbert J, duBois R,
Schwarz MI, Schwartz D, Lynch DA. High Resolution CT Findings in Patients with Familial
Interstitial Pneumonia. In Press
30
121.
122.
123.
124.
125.
126.
127.
YangYV, Coldren CD, Leach SM, Murphy E, Lin V, Burton R, Groshung S, Cool CT, Cosgrove
GP, Lynch D, Brown KK, Schwarz MI, Fingerlin TE, Schwartz DA. Expression of cilium
associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. In Press
The idiopathic pulmonary fibrosis clinical research network (IPFnet) A Placebo controlled
Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. Schwarz MI, chair of IPF net
steering and publication committees. In press
Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet) A placebo controlled
randomized trial of prednisone, azathiopine thioprine, and N-Acetylcysteine in Idiopathic
pulmonary Fibrosis. Schwarz MI, Chair of IPF Net steering, Excutive and Publication committees.
In press
Peljto AL, Steele MP, Fingerlin TE, Hinchclill ME, Carns M, Schwarz MI, Varga J, Schwartz
DA. A common MUC5B polymorphism does not influence the development of systemic
scleroderma associated interstitial lung disease. In press
Lara AR, Cosgrove GP, Huie TJ, Burnham EL, Heinz D, Curran-Everett D, Sahin H, Schwarz MI,
Cool C, Groshong S, Geraci MW, Tuder RM, Hyde DM, Henson PM. Lymphangiogenesis and
fibrosis is associated with disease severity in the idiopathic interstitial pneumonias. In Press
Swigris JJ, Han M, Vij R, Noth I, Eisenstein ZL, Anstrom K, Brown KK, Fairclough D. For the
IPF network investigators. Longitudinal construct validity of the UCSD shortness of health
questionnaire in idiopathic pulmonary fibrosis. Schwarz MI, Chair of IPF Net steering, Executive
and publication committees. Submitted
Schwarz MI, Zhang Y, Richards TJ, Silveria LJ, Fingerlin TE, Peljito AL, Steele MP, Loud JE,
Brown KK, Seibold MA, Talbert JA, Markin C, Muphy E, Kaminski N, Schwatz DA. A common
MUC5B promotor polymorphism is associated with survival in idiopathic pulmonary fibrosis.
Submitted
II.
INVITED MANUSCRIPTS
1.
2.
Charles M, Schwarz MI: Pneumocystis carinii pneumonia. Postgrad Med 1973; 53:86
Matthay R, Schwarz MI, Petty TL: Pulmonary manifestations of the collagen vascular diseases.
Clin Notes Respir Dis 1977;16:3
Schwarz MI, Levin DE: Understanding Blood Gases. Breon Laboratories Inc., Chicago, 1977
Schwarz MI: Idiopathic interstitial pneumonitis. Semin Respir Med 1979; 1:47
Schwarz MI: Interstitial and pulmonary vascular disease. MKSAP VII, American College of
Physicians 1984
Schwarz MI: Diagnosis of sarcoidosis. Clin Derm 1986; 4:165
Schwarz MI: The 28th Aspen Lung Conference: Interstitial Lung Disease. Chest (Suppl) 1986;
89:107S
Schwarz MI: Idiopathic pulmonary fibrosis. West J Med 1988; 149:199
Schwarz MI: Pulmonary and cardiac disease in polymyositis/dermatomyositis. J of Thoracic
Imaging 1992; 7:46-54
Schwarz MI: Interstitial lung disease associated with bronchiolitis, eosinophilic granuloma and
other unique entities. Semin Respir Med 1993; 14:375-388
Schwarz MI: Interstitial lung disease. In MKSAP in the Subspecialty of Pulmonary Medicine and
Critical Care, American College of Physicians 1994
Sullivan E, Schwarz MI: Pulmonary amyloidosis: an unusual cause of primary pulmonary
hypertension. Semin Respir Med 1994; 15:238-242
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
31
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
Schwarz MI: Pulmonary capillaritis. Pulmonary Perspectives 1994; 11(4)
Schwarz MI, Jennings C, Cherniack RM, King TE: Idiopathic pulmonary fibrosis, 50th Interstitial
Lung Disease Research Conference, Yamanouchi Pharmaceutical Co., Tokyo, Japan 1995; 1-38.
Schwarz MI: Acute Interstitial Lung Disease, Comprehensive Therapy 1996; 22:622-630.
Schwarz MI: Pulmonary hemorrhage syndromes, UpToDate in Pulmonary and Critical Care
Medicine (CD-ROM), American Thoracic Society, 1996.
Nicolls MR, Weiss SM, Schwarz MI: Panbronchiolitis: recognition and treatment. Infections in
Medicine, 1998; 15:657-661.
Schwarz MI: Non-granulomatous vasculitis. Semin Respir Crit Care Med, 1998; 19:47-56.
Schwarz MI: Lung involvement in polymyositis. Clin Chest Med, 1998; 19:701-712.
Schwarz MI: Non-smoking related obstructive lung diseases in the USA. The 23rd symposium
on Diffuse Panbronchiolitis, Therapeutic Research 1997; 18:28-30.
Girod CE, Schwarz MI: Pulmonary manifestations of mixed connective tissue disease. Semin
Respir Crit Care Med, 1999; 20:99-108.
Schwarz, MI. A man with dyspnea, productive cough and a chest radiograph showing
hyperinflation and a diffuse nodular pattern. Chest 1998; 113:1123-1124.
Schwarz MI, Brown KK. Small vessel vasculitis of the lungs. Thorax 2000; 55:502-510.
Schwarz MI, A 54-year-old man who complains of the gradual onset of dyspnea and nonproductive cough has hypoxemia and abnormal chest imaging studies. Chest 2000; 118:11981201.
Vourlekis J, Brown K, Schwarz MI. Acute interstitial pneumonia. Sem Respir Crit Care Med
2001;22:399-408.
Schwarz MI. A 60-year-old man with recurrent pneumonias. Chest 2001; 119:1590-1592.
Schwarz MI. A 51-year-old male with a complicated medical history and abnormal chest
radiographic findings. Chest 2001; 119:1948-1950.
Schwarz MI. A 64-year-old man presents with hemoptysis, past history of oral ulcers, and an
abnormal chest radiograph. Chest 2003; 123:617-618.
Brown KK, Schwarz MI. Idiopathic pulmonary fibrosis, Respiratory Special Edition, McMahon
Publishing Group. In Press.
Schwarz MI, Fontenot A. Drug-induced vasculitis and pulmonary hemorrhage syndromes. Clinics
Chest Med. 2004; 25:133-140.
Schwarz MI. A woman who began complaining of dyspnea and cough five months ago is now in
respiratory distress. Chest 2003; 124:2388-2390.
Collard HR. Schwarz MI. Diffuse alveolar hemorrhage syndromes. Clinics Chest Med. 2005;
25:583-589.
Solomon J, Schwarz, MI. Drug, toxic agents, and radiation induced eosinophilic pneumonia. Sem
Respir Crit Care Med. 2006; 27:192-197
Cosgrove G, Schwarz MI. Mimics of COPD. International Journal of COPD. In Press
Olson A, Cosgrove G, Brown KK, Schwarz MI. Case records from the University of Colorado:
A 64 year old man with pneumonia and pleural effusion. Chest 2006; 130: 1929-1934.
Boe DM, Schwarz MI. Case records from the University of Colorado: A 31 year old man with
chronic cough and hemoptysis. Chest 2007; 132: 721-726.
Risbano MG, Groshong SD, Schwarz MI. Case records from the University of Colorado: Lung
nodules in a woman with breast cancer. Chest 2007; 132: 1697-1701
Lara A, Schwarz MI. Diffuse Alveolar Hemorrhage. Chest 2010; 137: 1164-1171
32
39.
48.
Boe DM, Schwarz MI, Groshong SD, Maloney JP. A 64 Year Old Woman with a History of
Rheumatoid Arthritis and New Cavitary Lung Lesions. Chest 2007; 132: 2046
Benson A, Schwarz MI. Case Records from the University of Colorado, Recurrent Hemoptysis in
a 26 Year Old Woman. Chest 2008; 134: 1325-1331
Sergew A, Schwarz MI. Case Records from the University of Colorado, A 25 year old woman
with diffuse abdominal pain and shock. Chest 2008; 136:1435-1440
Schwarz MI. Clinical year in review, Interstitial Lung Disease. Proc Am Thorc Soc 2008; 751752
Frankel S, Schwarz MI. Update in idiopathic pulmonary fibrosis OP in Pub Med 2009; 15: 463469
Bedient TJ, Chan ED, Schwarz MI, Groshong SD, Case records from the University of Colorado.
A 45 year old man with a history of hepatitis and testicular cancer presents with cavitary lung
lesions and palpable purpura. Chest 2009; 136:1168-1174
Vandervest KM, Schwarz MI, Case records from the University of Colorado. A 76 year old
woman with acute CNS symptoms and pulmonary nodules. Chest 2009; 136: 1686 – 1689
Macht M, Mitchell V, Cool C, Lynch DA, Babou A, Schwarz MI: A 31 year old woman with
trichoptysis and hemoptysis. Chest; 2010, 138: 213-219
Ferguson JH, Fisher J, Schwarz MI: A 51 year old man with dysphasia, anorexia, and night
sweats. Chest 2010; 138: 1260-1270
Frankle S, Schwarz MI, Pulmonary Vasculitis, Concise Clinical Review in Press
III.
EDITORIALS
1.
2.
Schwarz MI: Interstitial Lung Disease - Nine Years Later, Chest (Suppl), 1986; 89:107S
Schwarz MI: Pulmonary - Critical Care Medicine in the Era of Health Care Reform. Chest 1994;
106:986
Schwarz MI: An approach to evaluating the patient with interstitial lung disease. Hosp Prac
1995; 30:11
Schwarz MI: The treatment of Idiopathic Pulmonary Fibrosis. What does the future behold?
Chest 1995; 108:601
Schwarz MI: A new focus for the treatment of pulmonary fibrosis. MD Consult (on-line).
Pulmonary and Critical Care Medicine, 2002
Schwarz MI: Fibroproliferation: a new therapeutic target for idiopathic pulmonary fibrosis. In
Press: Pneumon.
Schwarz MI: Fibroproliferation: A new direction in the treatment of idiopathic pulmonary
fibrosis. [Perspectives] MD Consult, Respiratory and Critical Care Medicine, Jan 22, 2002.
Schwarz MI: Capillary bleeding in the lungs: [Perspectives] MD Consult, Respiratory and Critical
Care Medicine. July 18, 2002
Schwarz MI: The Bottom Line is Fibrosis, but what about Inflammation? [Perspectives] MD
Consult, Respiratory and Critical Care Medicine, 2003
Schwarz MI: The Genetic Aspects of the Pathobiology of Idiopathic Pulmonary Fibrosis. MD
Consult, Respiratory and Critical Medicine. MD Consult, 2003
Churg A, Schwarz, MI: Transbronchial Lung Biopsy and Usual Interstitial Pneumonia: A New
Paradigm In Diagnosis? Chest 2006; 129: 1117-1118
Brown KK, Schwarz MI. Classifying Interstitial Lung Disease: remembrance of things past.
Chest 2007; 130: 1289-1290
40.
41.
42.
43.
44.
45.
46.
47.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
33
13.
Schwarz MI: Thomas L. Petty (1932 – 2009): A Tribute. Am J Resp Cirt Care Med 2010
IV. BOOKS
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
Schwarz MI, King TE: Interstitial Lung Disease. BC Decker Inc., Toronto, Philadelphia, 1988
Mitchell RS, Petty TL, Schwarz MI: Synopsis of Clinical Pulmonary Disease (4th Ed.)
C.V. Mosby Co., St. Louis, Toronto, London 1989
Schwarz MI: Pulmonary Grand Rounds, B.C. Decker Inc., Toronto, Philadelphia, 1989
Schwarz MI, King TE: Interstitial Lung Disease, Japanese Language version, Igaka-Shoin Ltd.,
Tokyo, 1991
Schwarz MI, King TE: Interstitial Lung Disease. 2nd Edition. Mosby-Year Book, Inc.,
Philadelphia, 1993
Schwarz MI: Pulmonary and Critical Care Section, Co-Editor Case Oriented Studies in Internal
Medicine. Schrier, R (ed). Little-Brown Co., Boston, Toronto. 1994
Schwarz MI, King TE: Interstitial Lung Disease, 3rd Edition. B.C. Decker, Inc., Hamilton,
Ontario, 1998
Schwarz MI: Pulmonary Grand Rounds II, B.C. Decker, Inc, Hamilton, Ontario, In Press
Cherniack RM, Schwarz MI: The treatment of Pulmonary Disease, B.C. Decker, Inc. Hamilton,
Ontario, In Press
Schwarz MI, King TE: Interstitial Lung Disease. 4th Edition, B.C. Decker, Inc., Hamilton, Ontario,
2003
Chan ED, Welsh CH, Schwarz MI:. The Bedside Pulmonary Consultant, In Preparation
Schwarz, MI, King, TE: Interstitial Lung Disease. 5th Edition, Peoples Medical Publishing House,
Shelton Connecticut 2011.
V.
BOOK CHAPTERS
1.
Schwarz MI: Lung Structure as Related to Function. In Synopsis of Clinical Pulmonary Disease,
edited by Mitchell RS, C.V. Mosby Company, St. Louis, Missouri, 1974, pp. 1-10
Schwarz MI: Pulmonary Medicine. In Problem Oriented Medical Diagnosis, edited by Papper S
and Friedman H, Little Brown and Company, Boston, Massachusetts, 1975, pp. 139-177
Schwarz MI: Open Lung Biopsy and Mediastinoscopy. In Pulmonary Diagnostic Techniques,
edited by Petty TL, Lea and Febiger, Philadelphia, Pennsylvania, 1975, pp. 243-249
Schwarz MI: Sarcoidosis. In Synopsis of Pulmonary Disease, 2nd Edition, C.V. Mosby Company,
St. Louis, Missouri, 1978 pp. 283-290
Schwarz MI: The Interstitial Pneumonias. In Synopsis of Pulmonary Disease, 2nd Edition,
C.V. Mosby Company, St. Louis, Missouri, 1978, pp. 241-470
Schwarz MI: Lung Structure as Related to Function. In Synopsis of Pulmonary Disease, 2nd
Edition, C.V. Mosby Company, St. Louis, Missouri, 1978, pp. 1-8
King TE, Schwarz MI: Pleuropulmonary Manifestations of the Collagen Vascular Disorders. In
Synopsis of Clinical Pulmonary Disease, 3rd Edition, Mitchell RS and Petty TL (eds),
C.V. Mosby, St. Louis, Missouri, 1982
Schwarz MI: Sarcoidosis. In Synopsis of Clinical Pulmonary Disease, 3rd Edition, Mitchell
RS and Petty TL (eds), C.V. Mosby, St. Louis, Missouri, 1982
Schwarz MI: Interstitial Lung Disease. In Synopsis of Clinical Pulmonary Disease, 3rd Edition,
Mitchell RS and Petty TL (eds), C.V. Mosby, St. Louis, Missouri, 1982
2.
3.
4.
5.
6.
7.
8.
9.
34
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
King TE, Schwarz MI: Pulmonary Function and Disease in the Elderly. In Clinical Internal
Medicine in the Elderly, Schrier RW (ed), WB Saunders Company, Philadelphia, Pennsylvania,
1982
Schwarz MI, Cox P: Pulmonary Medicine. In Problem Oriented Medical Diagnosis, 3rd Edition,
Friedman H (ed), Little Brown and Company, Boston, Massachusetts, 1983
Schwarz MI, King TE: Treatment of Interstitial Lung Disease. In Treatment of Pulmonary
Disease, Cherniack R (ed), B.C. Decker, Toronto, 1984
Schwarz MI, King TE: Treatment of Interstitial Lung Disease. In Current Therapy in Internal
Medicine, Brain T and Cherniack RM (ed), B.C. Decker, Toronto, 1984
Schwarz MI, Cox P: Pulmonary Medicine. In Problem Oriented Medical Diagnosis, 4th Edition,
Petty TL and Schwarz MI (eds), C.V. Mosby Company, St. Louis, Toronto, London, 1989
Schwarz MI: Radiologic Manifestations of Diffuse Lung Disease. In Interstitial Lung Disease,
Schwarz MI and King TE (eds), B.C. Decker, Toronto, 1988
Schwarz MI: Lymphocytic Interstitial Pneumonia. In Interstitial Lung Disease, Schwarz MI and
King TE (eds), B.C. Decker, Toronto, Philadelphia, 1988
Shoemaker SA, Schwarz MI: Respiratory Disease in Medicine. In Diagnosis and Treatment, 2nd
Edition, Robert E. Schrier (ed), Little Brown and Co., Boston, Massachusetts, 1988
Schwarz MI: Miscellaneous Causes of Interstitial Disease. In Interstitial Lung Disease, Schwarz
MI and King TE (eds), B.C. Decker, Toronto, Philadelphia, 1988
Schwarz MI: Approach to the Patient with Interstitial Lung Disease. In Textbook of Internal
Medicine, Kelly WN (ed), J.B. Lippincott Company, Philadelphia, 1989
Schwarz MI: Idiopathic Pulmonary Fibrosis. In Textbook of Internal Medicine, Kelly WN (ed),
J.B. Lippincott Company, Philadelphia, 1989
Schwarz MI: Chest Roentgenograph in the Evaluation of the Patient with Lung Disease. In
Textbook of Internal Medicine, Kelly WN (ed), J.B. Lippincott Company, Philadelphia, 1989
Schwarz MI: Idiopathic Pulmonary Fibrosis. In Synopsis of Clinical Pulmonary Disease, 4th
Edition, Petty TL and Schwarz MI (eds), C.V. Mosby Company, St. Louis, Toronto, London, 1989
Schwarz MI: Sarcoidosis. In Synopsis of Clinical Pulmonary Disease, 4th Edition, Petty TL and
Schwarz MI (eds), C.V. Mosby Company, St. Louis, Toronto, London, 1989
Schwarz MI: Other Diffuse Lung Disease. In Synopsis of Clinical Pulmonary Disease, 4th
Edition, Petty TL and Schwarz MI (eds), C.V. Mosby Company, St. Louis, Toronto, London, 1989
Schwarz MI: Diffuse Alveolar Filling Diseases. In Pulmonary Grand Rounds, Schwarz MI (ed),
B.C. Decker Inc., Philadelphia, Toronto, 1989
Hudson LD, Schwarz MI: Acute Respiratory Failure and the Adult Respiratory Distress
Syndrome. In Pulmonary Grand Rounds. Schwarz MI (ed), B.C. Decker Inc., Philadelphia,
Toronto, 1989
Schwarz MI, Watters LC, King TE et al: The Diagnosis and Assessment of the Course of
Idiopathic Pulmonary Fibrosis. In Interstitial Pneumonia of Unknown Etiology. Publication No.
27 of the Japan Intractable Diseases Research Foundation, Harasawa M, Fukuchi Y, Morinari H
(eds), University of Tokyo Press, 1989
Schwarz MI, Watters LC, Waldren JA et al: The Relationship of Bronchoalveolar Lavage Fluid
and Cellular Constituents with Histopathology and Therapeutic Responsiveness in Idiopathic
Pulmonary Fibrosis. In Interstitial Pneumonia of Unknown Etiology. Publication No. 27 of the
Japan Intractable Diseases Research Foundation, Harasawa M, Fukuchi Y, Morinari H (eds),
University of Tokyo Press, 1989
35
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
Schwarz MI: Approach to the patient with Interstitial Lung Disease. In Textbook of Internal
Medicine. 2nd Edition, Kelly WN (ed), J.B. Lippincott and Company, Toronto, Philadelphia.
1991
Schwarz MI: Idiopathic Pulmonary Fibrosis. In Textbook of Internal Medicine. 2nd Edition,
Kelly, WN (ed), J.B. Lippincott and Company, Toronto, Philadelphia. 1991
Schwarz MI, Cox P: Pulmonary Medicine. In Problem Oriented Medical Diagnosis. 5th Edition.
Friedman H, (ed). Little Brown Co., 1991
Schwarz MI: Acute Pneumonia In The ICU. In Critical Care Secrets. Weiner-Kronish J, Parsons
P (eds). Hanley and Belfus, 1992
Schwarz MI: Clinical Overview of the Interstitial Lung Diseases. In Interstitial Lung Disease.
2nd Edition, Schwarz MI, King TE (eds). B.C. Decker, Toronto, Philadelphia, 1993
Schwarz MI: The Primary and Unclassified Interstitial Lung Diseases. In Interstitial Lung
Disease. 2nd Edition. Schwarz MI, King TE (eds). Mosby Year Book, Philadelphia, 1993
Schwarz MI: The Lymphoplasmocytic Interstitial Pneumonias. In Interstitial Lung Disease. 2nd
Edition, Schwarz MI, King TE (eds). Mosby Year Book, Philadelphia, 1993
Schwarz MI: Pulmonary Manifestations of the Collagen Vascular Diseases. In Textbook of
Pulmonary and Critical Care Medicine. Reynolds HR, Bone RC (eds). Mosby Year Book,
Philadelphia, 1993
Schwarz MI, King TE, Cherniack RM: Interstitial Lung Disease: General Principals and
Diagnostic Approach. In Textbook of Respiratory Medicine. 2nd Edition. Murray JF, Nadel JA
(eds). WB Saunders Co., 1994
King TE, Cherniack RM, Schwarz MI: Idiopathic Pulmonary Fibrosis. In Textbook of
Respiratory Medicine. 2nd Edition. Murray JF, Nadel JA (eds). WB Saunders Co., 1994
King TE, Cherniack RM, Schwarz MI: The Lungs And Connective Tissue Disease. In Textbook
of Respiratory Medicine. 2nd Edition. Murray JF, Nadel JA (eds). WB Saunders Co., 1994
Schwarz MI, Cherniack RM, King TE: Diffuse Alveolar Hemorrhage and Other Rare Infiltrative
Disorders. In Textbook of Respiratory Medicine. 2nd Edition. Murray JF, Nadel JA (eds). WB
Saunders Co., 1994
Schwarz MI: Approach to the patient with Interstitial Lung Disease. In Essentials of Internal
Medicine. Kelly WN (ed). JB Lippincott and Company, 1994
Schwarz MI: Idiopathic Pulmonary Fibrosis. In Essentials of Internal Medicine. Kelly WN (ed).
JB Lippincott and Company, 1994
Cox P, Schwarz MI: Pulmonary Medicine. In Problem Oriented Medical Diagnosis. 6th Edition.
H. Friedman (ed). Little Brown Co., 1996.
Schwarz MI: Collagen Vascular Disease. In Pulmonary and Respiratory Therapy Secrets.
Parsons PE, Heffner JE (eds). Hanley and Belfus, Inc., 1997.
Schwarz MI: Pulmonary Manifestations of Collagen Vascular Disease. In Pulmonary Diseases
and Disorders. 3rd Edition. Fishman AP (ed). McGraw-Hill, 1998.
Schwarz MI: Pulmonary Manifestations of the Collagen Vascular Diseases. In Textbook of
Pulmonary and Critical Care Medicine. Reynolds HR, Bone RC (eds). Mosby Year Book,
Philadelphia, 1997.
Schwarz MI: A General Approach to the Understanding, Diagnosis and Management of
Interstitial Lung Disease. In Interstitial Lung Disease, 3rd Edition. Schwarz MI, King TE (eds).
B.C. Decker, Inc., 1998.
Schwarz MI: Diffuse Alveolar Hemorrhage. In Interstitial Lung Disease. 3rd Edition. Schwarz
MI, King TE (eds). B.C. Decker, Inc., 1998.
36
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
Schwarz MI: Miscellaneous Interstitial Lung Disease. In Interstitial Lung Disease. 3rd Edition.
Schwarz MI, King TE (eds). B.C. Decker, Inc., 1998.
Schwarz MI: Lymphoplasmocytic Infiltrations of the Lungs. In Interstitial Lung Disease. 3rd
Edition. Schwarz MI, King TE (eds). B.C. Decker, Inc, 1998.
Schwarz MI, Lynch D: Metabolic Diseases. In Diffuse Lung Disorders: A Comprehensive
Clinical-Radiologic Overview. Sperber M (ed). Springer-Verlag Publishers, London, 1998.
Schwarz MI, Lynch D: Diffuse Interstitial Pulmonary Fibrosis. In Diffuse Lung Disorders: A
Comprehensive Clinical-Radiologic Overview. Sperber M (ed). Springer-Verlag Publishers,
London, 1998.
Schwarz MI: Acute pneumonia In The ICU. In Critical Care Secrets. Weiner-Kronish J, Parsons
P (eds). 2nd Edition. Hanley and Belfus, 1997.
King TE, Schwarz MI: Medical Management Of Interstitial Lung Disease. In Medical
Management of Pulmonary Disease. Davis GS (ed). Marcel Decker, Inc. 1999
Schwarz MI: Pulmonary vasculitidies and diffuse alveolar hemorrhage. In Principles of
Respiratory Medicine, Albert RK, Spiro S, Jett J (eds). Mosby International. 1999
Schwarz MI, King TE, Cherniack RM: Interstitial Lung Disease: General Principals and
Diagnostic Approach. In Textbook of Respiratory Medicine. 3rd Edition. Murray J, Nadel J,
Boushey H, Mason R (eds). WB Saunders Co., 2000.
King TE, Cherniack RM, Schwarz MI: Idiopathic Pulmonary Fibrosis. In Textbook of
Respiratory Medicine. 3rd Edition. Murray J, Nadel J, Boushey H, Mason R (eds). WB Saunders
Co., 2000.
King TE, Cherniack RM, Schwarz MI: The Lungs And Connective Tissue Disease. In Textbook
of Respiratory Medicine. 3rd Edition. . Murray J, Nadel J, Boushey H, Mason R (eds). WB
Saunders Co., 2000.
Schwarz MI, Cherniack RM, King TE: Diffuse Alveolar Hemorrhage and Other Rare Infiltrative
Disorders. In Textbook of Respiratory Medicine. 3rd Edition. Murray J, Nadel J, Boushey H,
Mason R (eds). WB Saunders Co., 2000.
Schwarz MI: (Co-Editor). Pulmonology in The Internal Medicine Casebook: Real patients, Real
Answers, 2nd Edition. Schrier R (ed). Little Brown Co, 1999.
Girod CE, Schwarz MI: Airway Disease in Diffuse Parenchymal Lung disease. In Chronic
Obstructive Pulmonary Disease. Voelkel N, MacNee B (eds). BC Decker, 2001.
Fontenot A, Schwarz MI: Immunologic lung disease. In: Clinical Immunology, 2nd edition. Rich
RR, Fleisher TA, Shearer WT, Schroeder HW, Kotzin B (eds). Harcourt International, London,
pps 84.1-84.23, 2001.
Schwarz MI: Evaluation of patient with pulmonary-renal syndrome. In: Internal Medicine Pearls,
Heffner JE, Sahn SA (eds), Hanley and Belfus, Inc., 2002.
Schwarz MI: Collagen vascular disease, In: Pulmonary/Respiratory Therapy Secrets, 2nd Edition,
Parsons PE, Heffner JE, (eds). Hanley and Belfus, Inc. Philadelphia. 2002.
Cox PM, Schwarz MI: Respiratory problems in problem oriented medical diagnosis. 7th Ed.,
Friedman HH (ed), Lippincott Williams and Wilkins, 2000.
Schwarz MI, Raghu G, King TE: An approach to interstitial lung disease. In: Interstitial Lung
Disease, 4th Ed., Schwarz MI, King TE (eds). BC Decker, Hamilton. 2003.
Schwarz MI, Brown KK: The future of medical therapy for lung fibrosis. In: Interstitial Lung
Disease, 4th Ed., Schwarz MI, King TE (eds). BC Decker, Hamilton. 2003.
Schwarz MI, Fontenot A: Diffuse Alveolar hemorrhage. In: Interstitial Lung Disease, 4th Ed.,
Schwarz MI, King TE (eds). BC Decker, Hamilton. 2003.
37
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
Cosgrove G, Fessler M, Schwarz MI: Lymphoplasmocytic infiltrations of the lung. In: Interstitial
Lung Disease, 4th Ed., Schwarz MI, King TE (eds). BC Decker, Hamilton. 2003.
Schwarz MI: Other interstitial lung disease. In: Interstitial Lung Disease, 4th Ed., Schwarz MI,
King TE (eds). BC Decker, Hamilton. 2003.
Brown KK, Schwarz MI: Future Directions in therapy of Idiopathic Pulmonary Fibrosis. In: Lung
Biology in Health and Disease: Idiopathic Pulmonary Fibrosis, Lynch J, (ed), Marcel Dekker Inc.,
2003.
Girod CE, Schwarz MI: Diseases of the upper airway causing airflow limitation. In: Chronic
Obstructive Lung Disease. Voelkel N, MacNee W (eds), BC Decker, 2001.
Schwarz MI: Acute pneumonia in the ICU. In: Critical Care Secrets. Weiner-Kronish J, Parson P
(eds). 3rd Edition, Hanley and Belfus, 2002.
Fontenot A, Schwarz MI: Diffuse alveolar hemorrhage. In: Textbook of Pulmonary Diseases, 7th
Edition, Crapo J, Glassroth J, Karlinsky J, King TE (eds). Lippincott, Williams and Wilkins,
Philadelphia. 2004.
Cosgrove G, Schwarz MI: Vasculitis and diffuse alveolar hemorrhage. In: Current Diagnosis and
Treatment of Pulmonary Disease. Welsh C, Hanley M, (eds), McGraw Hill. 2003.
Schwarz MI: Acute Interstitial Pneumonia. In treatment strategies in Pulmonary Disease,
PocketMedicine.com, Inc. In Press
King TE, Schwarz MI: Approach to the diagnosis and management of the idiopathic interstitial
pneumonias. In Textbook of Respiratory Medicine. 4th Edition. Mason R, Broadhouse C, Murray
L, Nadel J (eds). WB Saunders Co., 2005.
Schwarz MI, Collard HR, King TE: Diffuse Alveolar Hemorrhage and Other Rare Infiltrative
Disorders. In Textbook of Respiratory Medicine. 4th Edition. Mason R, Broadhouse C, Murray L,
Nadel J (eds). WB Saunders Co., 2005.
Schwarz MI: Pulmonary Syndromes: In: The Merck Manual, 18th Edition. 2005.
Collard HR, Schwarz MI: Hypersensitivity Pneumonitis in Bones Atlas of Pulmonary Medicine,
3rd edition; James Crapo (ed), Current Medicine Inc, 2004.
Schwarz MI: Pulmonary vasculitis and hemorrhage in Clinical Respiratory Medicine, 2nd Edition,
Albert A, Spiro S, Jett J (eds). Elsevier, Philadelphia. 2004.
Fitzgerald J, Schwarz MI: Vasculitis and Pulmonary-Renal Syndromes in Respiratory
Emergencies, Fein A, Kamholz S, Ost D (eds). Edward Arnold, Ltd., London. 2006
Schwarz MI: Collagen Vascular Disease, In Pulmonary/Respiratory Secrets, 3rd ed., Parsons PE,
Heffner JE (eds), Hanley and Belfus, Inc 2005.
Collard HR, Schwarz MI: Diffuse Alveolar Hemorrhage and Goodpastures Syndrome in
Encyclopedia of Respiratory Medicine, Laurent G, Shapiro S (eds), Elsevier, Oxford. 2006
Frankel S, Schwarz MI. Cardiopulmonary manifestations of vasculitis in Vasculitis, 2nd Edition,
Ball GV, Bridges SL (eds), Oxford University Press. 2008
Cosgrove G, Schwarz MI: Lymphomatoid Granulomatosis in Encyclopedia of Respiratory
Medicine, Laurent G, Shapiro S (eds), Elsevier, Oxford. 2006
Cosgrove G, Schwarz MI. Pulmonary manifestations of the collagen vascular diseases in
Fishmans Pulmonary Diseases and Disorders, 4th Edition, Fishman A, Fishman J, Grippi M, Senior
RM, Elias J (eds), McGraw Hill Inc. 2008.
Olson A, Schwarz MI. Diffuse Alveolar Hemorrhage in Progress in Respiratory Research, Vol.
23, Diffuse Parenchymal Lung Disease, Costabel E, du Bois R, Egin J (eds), Karger. 2006 In
Press.
38
89.
90.
91.
92.
93.
Fontenot, A, Schwarz MI: Immunologic lung disease. In: Clinical Immunology, 3rd edition. Rich
RR, Fleisher TA, Shearer WT, Schroeder HW, Kotzin B (eds). Harcourt International, London,
pps 84.1-84.23, 2008.
Schwarz, MI: Drug induced alveolar hemorrhage in Drug Induced and Iatrogenic Lung Disease
Rosenow E, Camus P (eds) Hodder and Arnold in press
Schwarz, MI: “Pulmonary” in The Internal Medicine Casebook: Real patients, Real Answers, 3rd
edition. Schrier R (ed). Little Brown Co, 2006.
Schwarz, MI: Collagen Vascular Disease in Pulmonary/Critical Care Secrets, 3rd Edition, Parsons
P, Heffner J, (eds), Mosby Inc. In Press. 2006
Cosgrove G, Schwarz MI,: An approach to interstitial lung disease. In: Interstitial Lung Disease,
5th Ed., Schwarz MI, King TE (eds). Peoples Medical Publishing House, Shelton, Connecticut
2011.
94.
Lara A., Frankel S., Schwarz MI,: Diffuse Alveolar hemorrhage. In: Interstitial Lung Disease, 5th
Ed., Schwarz MI, King TE (eds). Peoples Medical Publishing House, Shelton Connecticut 2011.
95.
Cosgrove G, Fessler M, Schwarz MI: Lymphoplasmocytic infiltrations of the lung. In: Interstitial
Lung Disease, 5th Ed., Schwarz MI, King TE (eds). Peoples Medical Publishing House, Shelton
Connecticut 2011.
96.
Huie T, Schwarz MI: Miscellaneous interstitial lung disease. In: Interstitial Lung Disease, 5th Ed.,
Schwarz MI, King TE (eds). Peoples Medical Publishing House, Shelton Connecticut 2011.
97.
Schwarz MI: Pulmonary vasculitis and hemorrhage in Clinical Respiratory Medicine, 3rd Edition,
Albert A, Spiro S, Jett J (eds). Elsevier, Philadelphia. 2008.
Girod CE, Schwarz MI: Airway Disease in Diffuse Parenchymal Lung disease. In Chronic
Obstructive Pulmonary Disease. Voelkel N, MacNee B (eds). 2nd Edition 2008
Girod CE, Schwarz MI: Diseases of the upper airway causing airflow limitation. In: Chronic
Obstructive Lung Disease. Voelkel N, MacNee W (eds). 2nd Edition 2008
Lara A, Schwarz MI, Pulmonary Capillaritis in Diffuse in Interstitial Lung and Bronchiolar
Diseases. JE Lynch (ed.), Informa Healthcare, NYC, NY, In Press.
Collard HR, Schwarz MI. Hypersensitivity pneumonitis in Bones Atlas of Pulmonary Medicine
4th edition: James Crapo (ed.) Current Medicine Inc. 2007
Schwarz MI, Diffuse Alveolar Hemorrhage in Oxford American Handbook of Respiratory
Disease. Oxford University Press, 2007
Collard HR, King TE, Schwarz MI, Diffuse Alveolar Hemorrhage and Other Rare Infiltrate
Disorders. Textbook of Respiratory Medicine (5th Edition) Murray J, Nadel J, Mason R, Broaddos
G, Martin T, Schraufnagel D, King TE eds, WB Saunders. In Press.
Frankel S, Schwarz MI, Rare interstitial lung disorders: In diffuse lung diseases, a practical
approach, 2nd ed. Baughman RP, Dubois R (eds) Springer In Press
Schwarz MI, Diffuse alveolar hemorrhage and pulmonary renal syndromes. Merck Manual,
Professional Edition, 18th Edition, 2008
Olson A, Schwarz MI, Systemic lupus erythematosus in manual of pulmonary function: The
practical physiology. Mazzei JA, Mazzei ME, Barri A, D. Bartolo (g(eds), Thomas-Rueter,
Barcelona, Spain; 2009
98.
99.
100.
101.
102.
103.
104.
105.
106.
39
107.
108.
109.
110.
111.
112.
Schwarz MI, Diffuse alveolar hemorrhage and pulmonary renal syndromes. Merck Manual,
Professional Edition, 18th Edition, 2009
Olson A, Schwarz MI, Roman R, Schraufnagel, D: Interstitial Lung Disease in Breathing in
America: Diseases, Progress and Hope, (ed), American Thoracic Society 2010.
Lara A, Schwarz MI, Diffuse alveolar hemorrhage in Decisions in Medicine. Epub 2012
Fontenot AE, Schwarz MI: Immunologic lung disease in clinical immunology: principles and
practice. 44th Edition Rich R ceditor. Elsevier, LTD 2012
MacNeal K, Schwarz MI, Schwartz DA, Idiopathic Pulmonary Fibrosis in Clinical Genomics,
American College of Phyicians , McGraw Hill, 2012
Frankel S, Schwarz MI. Cardiopulmonary manifestations of vasculitis in Vasculitis, 2nd Edition,
Ball GV, Bridges SL (eds), Oxford University Press. 3rd edition, 2012
VI.
ABSTRACTS
1.
Weill H, George R, Schwarz MI, Ziskind MM: Evaluation of pulmonary function three years
after acute exposure to chlorine gas. Am Rev Respir Dis 1968; 98:191
Ziskind MM, Weill H, Herbert SJ, Shames JM, Schwarz MI, George RB: Effect of pulmonary
emphysema on bacterial lobar pneumonia. Am Rev Respir Dis 1969; 99:976
Schwarz MI, Sahn SA, Marmorstein BL, Sheinhorn DJ: Polymyositis lung. Chest 1974; 66:335
Matthay RA, Schwarz MI, Gupta RC, Steigerwald JC, Sahn SA, Stanford RE, Petty TL: Acute
lupus pneumonitis: the clinical spectrum. Chest 1974; 66:332
Schwarz MI, Levin DC, Matthay RA, LaForce FM: Bacteremic hemophilus pneumonia in the
adult. Clin Res 1974; 22:653A
Schwarz MI, Ellis J, Matthay RA, et al: Radiographic and hemodynamic comparison of
pulmonary hypertension in patients with severe airways obstruction. Chest 1975; 68:425
Fine R, Schwarz MI, Stanford RE, Filley G: Radiographic, histologic and physiologic correlations
in diffuse interstitial lung disease. Chest 1975; 68:411
Schwarz MI, Dreisin RB, Stanford RE, Laksminarayan S, McIntosh RM: Immunofluorescent
studies of lung tissue in pulmonary alveolar proteinosis. Am Rev Respir Dis 1976; 113:168
Dreisin RB, Schwarz MI, Theophilopoulos AN, Stanford RE: Circulating immune complexes and
lung immunoflourescence in the interstitial pneumonias. Am Rev Respir Dis 1977; 115:101
Schwarz MI, Dreisin RB, Stanford RE, Laksminarayan S: The role of immune complexes in
idiopathic interstitial pneumonia. Clin Res 1977; 25:422A
King TE, Schwarz MI, Pratt DS, Dreisin RB: Immune complex deposition in pulmonary
histiocytosis X. Clin Res 1978; 26:449A
Pratt DS, Schwarz MI, May JJ, Dreisin RB: Fulminant pulmonary interstitial fibrosis: final
common pathway or discrete disease? Am Rev Respir Dis 1978; 117:75
Pratt DS, Dreisin RB, Schwarz MI: Analytic model for the diagnosis of cryptogenic fibrosing
alveolitis. Am Rev Respir Dis 1978; 117:116
Shasby DM, Schwarz MI, Stanford RE, et al: Immune complex deposition in Wegener’s
granulomatosis. Clin Res 1979; 27:403A
Goodman M, Link D, Schwarz MI, et al: The comparison of the localization of IgA and secretory
component in human bronchial epithelium by immunofluorescence and peroxidase-labeled
antibodies. Chest 1979; 76:353.
King TE, Schwarz MI, LaForce FM: Cavitation and abscess formation following pulmonary
infarction. Am Rev Respir Dis 1982; 125:113S
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
40
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
King TE, Christopher KL, Zeballos J, Watters LC, Harbeck R, Wilcox M, Kervitsky A, Cherniack
RM, Stanford RE, Schwarz MI: Bronchoalveolar lavage, gallium-67 citrate lung scanning and
circulating immune complexes in the staging of idiopathic fibrosis (IPF): Correlation with
physiologic and morphologic features. Clin Res 1984; 32:63A
Watters LC, King TE, Christopher KL, Wilcox ML, Kervitsky AJ, Cherniack RM, Schwarz MI:
The effects of smoking and corticosteroid therapy on the proportion of neutrophils (PMNs) in
bronchoalveolar lavage fluid (BALF) from patients with idiopathic pulmonary fibrosis (IPF). Clin
Res 1984; 32:65A
King TE, Ryan JW, Christopher KL, Cherniack RM, Schwarz MI, Repine JE: Angiotension
converting enzyme (ACE), carboxypeptidase N (CPN) and neutrophils are elevated in
bronchoalveolar lavage fluid (BALF) from patients with idiopathic pulmonary fibrosis (IPF) but
only BALF neutrophils and neutrophil superoxide O2 stimulating activity predict IPF severity.
Clin Res 1984; 32:63A
Topilsky M, Watters L, Mason R, King TE, Schwarz MI, Cherniack RM: Detection of
differentiation antigens, HLA-DR and HLA-DS, on human pulmonary macrophages from patients
with interstitial lung disease. Am Rev Respir Dis, 1984
Topilsky M, Watters L, Shields B, Mason R, King TE, Schwarz MI, Cherniack RM:
Characterization of human alveolar macrophages by monoclonal antibodies in interstitial lung
disease. Annals of the New York Academy of Sciences, 1984
King TE, Watters L, Christopher KL, Zeballos J, Harbeck R, Cherniack RM, Stanford RE,
Schwarz MI: Correlation of bronchoalveolar lavage (BAL) with routine clinical, radiographic,
physiologic and morphologic findings in idiopathic pulmonary fibrosis (IPF). International
Conference on Bronchoalveolar Lavage. May 1984
King TE, Watters LC, Ryan JW, Christopher KL, Schwarz MI, Cherniack RM, Repine JE:
Idiopathic pulmonary fibrosis (IPF). Neutrophils (PMNs), angiotensin converting enzyme (ACE),
and carboxypeptidase N (CPN) but not factors which stimulate PMN oxygen metabolite production predict disease severity. International Conference on Bronchoalveolar Lavage. Bethesda,
Maryland, May, 1984
Watters LC, King TE, Christopher KL, Cherniack RM, Schwarz MI: The effects of smoking and
corticosteroid therapy on the neutrophil (PMN) content of bronchoalveolar lavage fluid (BALF)
from patients with idiopathic pulmonary fibrosis (IPF). International Conference on
Bronchoalveolar Lavage. Bethesda, Maryland, May, 1984
Robinson PC, King TE, Watters LC, Hale SG, Schwarz MI, Mason RJ: Surfactant phospholipids
in bronchoalveolar lavage of patients with interstitial lung disease (ILD). Chest 1984; 86:300
Dunn TL, Watters LC, Hendrix C, Cherniack RM, Schwarz MI, King TE: The association
between volume loss and gas exchange abnormalities in sarcoidosis and idiopathic pulmonary
fibrosis. Clin Res 1985; 33:A76
Watters LC, King TE, Cherniack RM, Waldron JA, Stanford RE, Dunn TL, Christopher KL,
Schwarz MI: Bronchoalveolar lavage fluid lymphocyte content reflects the histologic alveolar
wall inflammation of idiopathic pulmonary fibrosis, whereas neutrophil content does not. Chest
(Suppl) 1986; 89:146S
Aguayo SM, Kane M, Schwarz MI, et al: Bombesin-like immunoreactivity in bronchoalveolar
lavage from smokers and interstitial lung disease. Clin Res 1987; 35:A530
King TE, Watters LC, Waldron JA, Cherniack RM, Schwarz MI: Bronchiolitis obliterans with
organizing pneumonia: Clinical presentation and bronchoalveolar lavage constituents
41
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
differentiates this process from idiopathic pulmonary fibrosis and sarcoidosis. Am Rev Respir Dis
1987; 135:348
Hanley ME, Watters L, King TE, Shen AS, Schwarz MI, Cherniack RM: The impact of smoking
on the mechanical properties of lungs in idiopathic pulmonary fibrosis and sarcoidosis. Am Rev
Respir Dis 1987; 135:347
Aguayo SM, King TE, Schwarz MI, Cherniack RM: Physiologic implications of honeycombing
in idiopathic pulmonary fibrosis and pulmonary histiocytosis X. Am Rev Respir Dis 1988;
137:194
King TE, Waldron JA, Cherniack RM, Nicolli SA, Wallace ME, Schwarz MI: Clinical
roentgenographical, physiologic and bronchoalveolar lavage reflect underlying histopathology in
hypersensitivity pneumonitis and predict response to therapy. Am Rev Respir Dis 1988; 137:312
Walker SR, Schwarz MI, Harbeck R, Wallace ME, Wilcox ML, Cherniack RM, King TE:
Ultrastructural immune deposits are present in the lungs of patients with interstitial Lung disease.
Am Rev Respir Dis 1988; 137:347
Bogin RM, Buschman DS, Cherniack RM, Schwarz MI, et al: The role of gallium lung scanning
in the evaluation of idiopathic pulmonary fibrosis. Chest 1988; 94:735
Bogin RM, Niccoli SA, Waldron JA, Cherniack RM, Thurlbeck WM, Flint A, Colby TV, Schwarz
MI, King TE: Respiratory bronchiolitis: Clinical presentation and bronchoalveolar lavage
findings. Chest 1988; 94:215
Aguayo SM, Kane MA, King TE, Schwarz MI et al: Increased levels of a bombesin like peptide
in the bronchoalveolar lavage fluid of smokers. J Cell Biochem 1988; 12A:C100
Bogin RM, Cherniack RM, Schwarz MI, Niccoli SA, King TE: Are the distinguishing features of
respiratory bronchiolitis attributable to smoking? Am Rev Respir Dis 1989; 139:A474.
Bogin RM, Buschman DS, Cherniack RM, Schwarz MI, King, TE: Gallium 67 lung scanning is
not helpful in predicting the clinical course of patients with idiopathic pulmonary fibrosis. Am
Rev Respir Dis 1989; 139:A193
Mortenson RL, Schwarz MI, Chernicak RM, Harbeck RJ, Watters LC, Niccoli SA, McDermott
TL, King TE: The clinical role of circulating immune complexes in idiopathic pulmonary
fibrosis. Am Rev Respir Dis 1989; 189:A192
Aguayo SM, Schwarz MI, Mortenson RL, et al: Differentiation of eosinophilic granuloma of the
lung from other interstitial lung diseases using clinical, physiologic, and bronchoalveolar lavage
criteria. Am Rev Respir Dis 1990; 141:A61
Aguayo SM, Schwarz MI, Mortenson RL, et al: The role of the chest radiograph in the evaluation
of disease sensitivity and clinical course in eosinophilic granuloma. Am Rev Respir Dis
1990:141;A319.
Mortenson RL, Colby TV, Lynch DA, Hutt MP, Cherniack RM, King TE, Schwarz MI: Severe
obstructive airway dysfunction and lung parenchymal over distention 13 and 20 years following
pulmonary capillaritis and recurrent diffuse alveolar hemorrhage. Am Rev Respir Dis 1992:145;
750
Baddini-Martinez JA, Mortenson RL, Bucher B, Schwarz MI, Cherniack RM, King TE, Jr.: Do
bronchoalveolar lavage cellular constituents at initial presentation predict survival in idiopathic
pulmonary fibrosis. Am Rev Resp Dis 1993; 147:480
Jennings CA, Tuder R, Cherniack RM, King TE, Schwarz MI: Pauci-immune pulmonary
capillaritis and diffuse alveolar hemorrhage: A vasculitis process limited to the lungs. J Invest
Med 1995; 43:143A
42
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
Schwarz MI, Sutarik J, Nick J, Leff J, Emlen JW, Tuder RM: Pulmonary capillaritis: A primary
manifestation of polymyositis. Am J Resp Crit Care Med 1995; 199:A199
Zamora MR, Warner ML, Tuder RM, Schwarz MI: Diffuse alveolar hemorrhage in patients with
systemic lupus erythematosus: Associations and effect on survival. Am J Resp Crit Care Med
1995; 151:A199
Jennings CA, Tuder RM, Cherniack RM, King TE, Schwarz MI: Pauci-immune pulmonary
capillaritis and diffuse alveolar hemorrhage: A vasculitic process limited to the lungs. Am J Resp
Crit Care Med 1995; 151:A199
Jennings CA, Bucher BL, Cherniack RM, Schwarz MI, King TE: IPF decrease in BAL
neutrophils associated with improved survival. Am J Resp Crit Care Med 1995; 151:A692
Jennings CA, Bucher BL, Cherniack RM, Schwarz MI, King TE: Apparent survival advantage in
smokers with IPF is related to higher flows and volumes at diagnosis. Am J Resp Crit Care Med
1995; 151:A693
Fitzgerald JE, King TE, Lynch DA, Tuder RM, Schwarz MI: Panbronchiolitis in the United
States. Am J Resp Crit Care Med 1996; 153:A273
Badesch DB, Zamora M, Fullerton D, Weill D, Tuder RM, Schwarz MI: Capillaritis: A
previously unrecognized form of rejection in lung transplant recipients. Am J Resp Crit Care Med
1996; 153:A151
Hodges TN, Schwarz MI, Zamora MR: Improvement of the native lung following single lung
transplantation (SLT) in patients with desquamative interstitial pneumonitis (DIP). Am J Resp
Crit Care Med 1997; 155:A149
Nick JA, Lynch D, Schwarz MI, Hanley ME: Chest pain as a complication of hereditary multiple
exostoses. Am J Resp Crit Care Med 1997; 155:A74
Schwarz MI, Zamora MR, Hodges TN, Chan ED, Bowler RP, Tuder RM: Isolated capillaritis and
diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Am J
Resp Crit Care Med 1998; 157:A67.
Morales DV, King TE, Schwarz MI, Brown KK: Desquamative interstitial pneumonia:
comparison to usual interstitial pneumonia (UIP)/idiopathic pulmonary fibrosis (IPF). Am J Resp
Crit Care Med 1999; 159:A65.
Brown KK, Taddei SC, West SG, King TE, Schwarz MI, Feghali CA, Wright TM: Antibodies
against th/to antigen in patients with idiopathic pulmonary fibrosis (IPF). Am J Resp Crit Care
Med 1999; 159:A68.
Brown KK, Schwarz MI, King TE, Kennedy MA, Kasham MA, Wenzel SE, Wright CD:
Dysregulation of matrix metalloproteinases (MMPs) in idiopathic pulmonary fibrosis. Am J Resp
Crit Care Med 2000; 161:A373.
Portnoy J, Schwarz MI, King TE, Cherniack RM, Brown KK: Respiratory bronchiolitis-interstitial
lung disease vs. IPF: comparison of outcome, clinical and physiologic variables. Am J Respir Crit
Care Med 2000; 161:A707.
Vourlekis JA, Brown KK, King TE, Schwarz MI: Recurrent acute interstitial pneumonitis. Am J
Respir Crit Care Med 2000; 161:A828.
Cosgrove GP, Schwarz MI, Geraci MW, Brown KK, Worthen GS: Overexpression of matrix
metalloproteinase-7 in pulmonary fibrosis. Aspen Lung Conference 2001. In Press.
Cosgrove GP, Schwarz MI, Geraci M, Brown KK, Worthen GS: Differential gene expression
between idiopathic pulmonary fibrosis and normal human lungs. Amer J Resp Crit Care Med
2001; 163:A44
43
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
Wahidi MM, Speer M, Steele M, Brown KK, Schwarz MI, Schwarz DA: Familial pulmonary
fibrosis in the USA. Amer J Resp Crit Care Med 2001; 163:A44
Fessler MB, Schwarz MI, King TE Jr., Brown KK: Lymphocytic interstitial pneumonitis vs. IPF:
comparison of outcome, clinical and physiologic variables. Amer J Resp Crit Care Med 2001;
163:A706
Vourlekis JS, Schwarz MI, Cool CD, Tuder RM, King TE Jr., Brown KK: Does pulmonary
fibrosis influence survival in hypersensitivity pneumonitis (HP)? Amer J Resp Crit Care Med
2001; 163:A747
Vourlekis JS, Brown KK, Cool CD, Tuder RM, King TE Jr., Schwarz MI: Nonspecific interstitial
pneumonitis (NSIP) can be the sole histologic lesion of hypersensitivity pneumonitis (HP). Amer
J Resp Crit Care Med 2001; 163:A982
King TE Jr., Schwarz MI, Brown KK, Tooze JA, Colby TV, Waldron JA Jr., Flint A, Thurlbeck
W, Cherniack RM: Extent of fibroblastic foci predict mortality in idiopathic pulmonary fibrosis
(IPF). Amer J Resp Crit Care Med 2001; 163:A982
King TE Jr., Tooze JA, Schwarz MI, Brown K, Cherniack RM: Prediction of survival in
idiopathic pulmonary fibrosis (IPF): development of a clinical, radiological, physiological scoring
system and survival model. Amer J Resp Crit Care Med 2001; 163:A985 .
Wahidi MM, Speer M, Brown K, Schwarz MI, Schwartz DA: Familial pulmonary fibrosis in the
USA. Europ J Hum Genetics 2001, 9:364.
Wahidi MM, Speer MC, Steele M, Brown KK, Schwarz MI, Schwartz DA: Familial pulmonary
fibrosis in the USA. Am J Hum Genetics 2001; 69: 28.
Wahidi MM, Speer MC, Steele MP, Brown KK, Schwarz MI, Schwartz DA: Familial pulmonary
Fibrosis. Chest Supplement, Aspen Lung Conference 2002; 121:30.
Collard HR, King TE, Vourlekis JV, Schwarz MI, Brown KK: Changes in clinical and physiologic
variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002;
115:B6.
Vourlekis JS, Cool CD, Colby TV, Yousem SA, Schwarz MI, Brown KK: An
immunohistochemical analysis of granulocyte-macrophage stimulating factor in pulmonary
alveolar proteinosis. Am J Respir Crit Care Med 2002; 165:A155.
Cosgrove GP, Brown KK, Cool CD, Geraci MW, Schwarz MI, Worthen GS: Angiogenesis in
idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 165:A172.
Vourlekis JV, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, King TE,
Brown KK: Determinants of survival in fibrotic hypersensitivity pneumonitis. Am J Respir Crit
Care Med 2002; 165:A198.
Schwarz MI, Bradford WZ, Starko K and IPF Study Group: Validation of the SF-36 as a quality of
life measure in patients with idiopathic pulmonary fibrosis. Chest 2002; 122:755.
Cosgrove GP, Brown KK, Geraci MW, Schwarz MI, Worthen GS: Molecular profiling
distinguishes idiopathic pulmonary fibrosis from nonspecific interstitial pneumonia. Amer J Resp
Crit Care Med 2003; 167:A991.
Portnoy J, Brown KK, Schwarz MI, Achcar R, Cool CD: Vascular alterations associated with
usual interstitial pneumonia (UIP). Amer J Resp Crit Care Med 2003; 167:A985.
Cosgrove GP, Brown KK, Henson PM, Schwarz MI, Worthen GS: Enhanced TGF-1 activity by
matrix metalloproteinase 7. Amer J Resp Crit Care Med 2003; 167:A841.
Cosgrove GP, Brown KK, Cool CD, Geraci MW, Schwarz MI, Worthen GS: Aberrant
angiogenesis in idiopathic pulmonary fibrosis. Amer J Resp Crit Care Med 2003; 167:A300.
44
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
Collard HR, Ryu JH, Douglas WW, King Jr., TE, Schwarz MI, Brown KK: High-dose
corticosteroid with or without cytotoxic therapy does not improve survival in idiopathic pulmonary
fibrosis/usual interstitial pneumonia (IPF/UIP). Amer J Resp Crit Care Med 2003; 167:A166.
Steele MP, Speer MC, Loyd JE, Brown KK, Phillips JA, Herron A, Schwarz MI, Schwartz DA:
Familial pulmonary fibrosis (FPF) in the United States: clinical characteristics and inheritance
pattern. Amer J Resp Crit Care Med 2004; 169:A550.
Yang IV, Burch LH, Steele MP, Savov JD, Hollingsworth JW, Berman KG, Brown KK, Schwarz
MI, Schwartz DA. Gene expression profiling distinguishes familial from non-familial forms of
pulmonary fibrosis. Proceedings of Am Thorac Soc, 2005; 2:A272.
Steele M, Brown K, Wahadi K, Leslie K, Cool C, Sporn T, McAdams M, Speer D, Lynch J,
Galvin J, Everett M, Schwarz MI, Schwartz DA. The contrasting histopathologic and radiologic
features of familial interstitial pneumonia (FIP) and idiopathic pulmonary fibrosis (S-IPF).
Proceedings of Am Thorac Soc, 2006; 3:A242.
Wise AL, Steele M, Speer MC, Loyd JE, Brown KK, Herron A, Burch LH, Schwarz MI, Schwartz
DA. Families with multiple types of idiopathic interstitial pneumonia have decreased survival.
Proc Amer Thorac Soc 2007; 175: 984
Wise AL, Speer MC, Steele MP, Burch LH, Herron H, Loyd VE, Brown KK, Phillips JA, Slifer
SH, Schwarz MI, Schwartz DA. Investigating Linkage to Chromosome 10 in Familial Interstitial
Pneumonia (FPF). Submitted
Kinder BW, Brown KK, McCormack FX, Ix JH, Kervitsky A, Schwarz MI, King TE Jr. Baseline
Serum Surfactant Protein-A Is a Predictor of Early Morality in Idiopathic Pulmonary Fibrosis.
Amer J Resp Crit Care Med 2008; 177:A43.
Zisman DA, Karlamangla AS, Kawut SM, Shlobin OA, Saggar R, Schwarz MI, Belperio JA,
Lynch JP III, Nathan SD. Validation of a Method To Screen for Pulmonary Hypertension in
Advanced Idiopathic Pulmonary Fibrosis. Amer J Resp Crit Care Med 2008, 177:A246.
Han MK, Bartholmai B, Curtis JL, Limper A, Sciurba FC, Bon JM, Robb RA, KarwoskiRA,
Frederick M, Thompson B, Li D, Flaherty KR, Schwarz MI, Martinez FJ. Emphysema Percent
Predicts Quality of Life and Symptoms in COPD: An Analysis of Lung Tissue Research
Consortium Patients. Amer J Resp Crit Care Med 2008; 177:A520.
Bartholmai BJ, Martinez FJ, Han MK, Curtis JL, Robb RA, Karwoski RA, Sciurba FC, Frederick
M, Li D, Thompson BW, Schwarz MI, Limper AH. Correlation of Radiologist Visual Assessment
of COPD Features with Quantitative Measures of Disease on Volumetric High-Resolution CT of
the Chest. A Lung Tissue Research Consortium (LTRC) Study. Amer J Resp Crit Care Med 2008;
177:A755.
Han MK, Bartholmai B, Flaherty KR, Limper A, Schwarz MI, Thannickal VJ, Frederick M,
Thompson B, Li D, Toews GB, Martinez FJ. Gender Differences in Emotional Function in
Patients with IPF: A Lung Tissue Research Consortium Study. Amer J Resp Crit Care Med 2008;
177:A886.
Wise AL, Speer MC, Steele MP, Burch LH, Herron A, Loyd JE, Brown RR, Phillips JA, Slifer
SH, Sporn TA, McAdams P, Schwarz MI, Schwartz DA. MUC5AC is a Candidate Gene for
Familial Pulmonary Fibrosis. Amer J Human Genetics
Zisman DA, Kawut SM, Lederer DJ, Belperio JA, Lynch III JP, Schwarz MI,. Tayek JA, Reuben
DB, Karlamangla AS. Serium Albumin Concentration and Waiting List Mortality in Idiopathic
Interstitial Pneumonia. Am J Respir Crit Care Med 179;2009:A1120
45
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
Boon K, Bailey NW, Tomfohr JK, Steele MP, Brown KK, Loyd JE, Schwarz MI, Schwartz DA.
Peripheral Blood Genomic Signatures in Familial Interstitial Pneumonia (FIP). Am J Respir Crit
Care Med 179;2009:A2171
Boon K, Bailey NW, Steele MP, Groshong S, Yang J, Kervitsky D, Brown KK, Schwarz MI,
Schwartz DA. Molecular Phenotypes Distinguish Rapid and Slow Disease Progression in
Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 179;2009:A2172
Burch LH, Wise AL, Garantziotis S, Evans CM, Adler KA, Speer AC, Steele MP, Brown KK,
Loyd JE, Gudmundsson G, Groshong SD, Dickey BF, Herron A, Kervitsky D, Talbert JL, Markin
C, Zhang L, Park J, Auerbach S, Crews AL, Slifer SH, Xu H, Potocky CF, Masinde T, Roy MG,
Jancewicz JW, Schwarz MI, Schwartz DA. Variants of MUC5AC Play a Role in the
Development of Pulmonary Fibrosis. Am J Respir Crit Care Med 179;2009:A2174
Han MK, Bartholmai B, Murray S, Curtis JL, Limper A, Sciurba F, Robb R, Karwoski R,
Frederick M, Thompson B, Li D, Flaherty KR, Schwarz MI, Martinez FJ. Quantified
Radiographic Measures Predict Cough and Self-Reported Acute Exacerbation Frequency in
COPD. Am J Respir Crit Care Med 179;2009:A6213
Coldren CD, Yang IV, Murphy J, Fingerlin T, Leach SM, Groshong S, Cool C, Gao B, Geraci
MW, Brown KK, Du Bois RM, Schwarz MI, Schwartz DA: Transcriptional Analysis and Subclassification of the idiopathic interstitial pneumonias; Aspen Lung Conference: 2010.
Berry CD, Drummon MB, Han MK, Limper AH, Martinez FJ, Schwarz MI, Sciurba FC, Wise
RA. Relationship Between SGRQ Score and Lung Function Differs By Diagnosis. ATS 2010
Schwarz MI, Silveria LJ, Seibold MA, Kummer N, Fingerlin TE, Murphy E, Cotter JD, Brown
KK, Steele MP, Loyd JE, Lynch DA, Bradford WZ, Szwarcberg J, Du Bois RM, Schwartz DA.
Non Synonymous Polymorphism in MUC5AC (Ala497Val) is Associated with Improved Survival
in Idiopathic Pulmonary Fibrosis. ATS 2010
Seibold MA, Lin J, Kervitsky D, Wescott J, Kummer N, Murphy R, Talbert J, Steele MP, Loyd
JE, Brown KK, Schwarz MI, Du Bois RM, Schwartz DA. The Concentration of MUC5AC is
higher in the air space in idiopathic pulmonary fibrosis (IPF) subjects and is associated with a
disease susceptibility variant (Ala497Val) in MUC5AC. ATS 2010
Lara AR, Cosgrove GP, Huie TJ, Schwarz MI, Henson PM. Serum Levels of Lymphangiogentic
Growth Factors Correlate with Disease Severity Based Airflow and Radiographic Abnormalities in
Interstitial Lung Disease. ATS 2010
Berry C, Han M, Limper A, Martinez F, Schwarz MI, Sciurba F, Wise RA. Older Adults with
Chronic Lung Disease Perceive Less Impairment. Am J Respir Crit Care Med., May 2011; 183:
A1491.
Donwang K, Tedrow J, Richards T, Schwartz D, Schwarz MI, Martinez F, Limper A,
Quackenbush J, Geraci M, Bartholmai B, Spira A, Tseng G, Sciurba F, Kaminski N.
Unsupervised Combination of Clinical And Gene Expression Data Elucidates Intermediate
Phenotypes in ILD and COPD. Am J Respir Crit Care Med., May 2011; 183: A4087
Coldren C, Leach S, Fingerlin T, Murphy E, Lin J, Cosgrove G, Lynch D, Groshong S, Brown K,
Schwarz MI, Yang I, Schwartz D. Is NSIP Really That Different From IPF? Am J Respir Crit
Care Med., May 2011; 183: A2265
Seibold M, Groshong S, Cosgrove S, Brown K, Schwarz MI, Reynolds S, Schwartz D. MUC5b is
The Predominant Mucin Expressed by the Bronchiolar Epithelium Lining of the Honeycomb Cyst.
Am J Respir Crit Care Med., May 2011; 183: A2338.
46
106.
107.
108.
109.
110.
Steele M, Brown K, Loyd J, Fingerlin T, Seibold M, Kummer N, Kervitsky D, Talbert J, Kidd R,
Markin C, Schwarz MI, Schwartz D. The Environment Influences the Risk of Developing
Familial Interstitial Pneumonia. Am J Respir Crit Care Med., May 2011; 183: A5690.
Steele M, Luna L, Yang, Cotter J, Talbert J, Leach S, Kidd R, Turner J, Kummer N, Boon K,
Brown K, Schwarz MI, Schwartz D. Peripheral Blood Biomarkers Differentiate Extent of Dico
(but not FVC) Changes for Idiopathic Pulmonary Fibrosis (IPF). Am J Respir Crit Care Med.,
May 2011; 183: A3558.
Yang I, Luna L, Coldren C, Fingerlin T, Leach S, Murphy E, Lin J, Cosgrove G, Lynch D,
Groshong S, Brown K, Schwarz MI, Schwartz D. Genes and Mirnas Associated with Severity of
Lung Function Impairment In Idiopathic Interstitial Pneumonias (IIPs). Am J Respir Crit Care
Med., May 2011; 183: A3559.
Cosgrove G, Groshong S, Talbert J, Kervitsky D, Delaney R, Kummer N, Markin C, Kidd R, Cool
C, Seibold M, Steele M, Loyd J, Brown K, Schwartz D, Schwarz MI . Familial Interstitial
Pneumonia (FIP) Is Similar Pathologically to Idiopathic Interstitial Pneumonia. Am J Respir Crit
Care Med., May 2011; 183: A1219.
Seibold M, Yang I, Silveria L, Coldren C, Fingerlin T, Leach S, Murphy E, Lin J, Kummer N,
Cosgrove G, Lynch D, Groshong S, Brown K, Schwartz D, Schwarz MI . Promoter Variant of
MUC5b Confirmed As An Idiopathic Interstitial Pneumonia (IIP) Risk Variant And Is Associated
With Upregulation of MUC5b Expression. Am J Respir Crit Care Med., May 2011; 183: A1219.